UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy
Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ý | ||
Filed by a Party other than the Registrant o |
||
Check the appropriate box: |
||
o |
Preliminary Proxy Statement |
|
o |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
ý |
Definitive Proxy Statement |
|
o |
Definitive Additional Materials |
|
o |
Soliciting Material Pursuant to §240.14a-12 |
THE ESTÉE LAUDER COMPANIES INC. | ||||
(Name of Registrant as Specified in Its Charter) |
||||
(Name of Person(s) Filing Proxy Statement, if other than the Registrant) |
||||
Payment of Filing Fee (Check the appropriate box): |
||||
ý |
No fee required. |
|||
o |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
|||
(1) | Title of each class of securities to which transaction applies: |
|||
(2) | Aggregate number of securities to which transaction applies: |
|||
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
|||
(4) | Proposed maximum aggregate value of transaction: |
|||
(5) | Total fee paid: |
|||
o |
Fee paid previously with preliminary materials. |
|||
o |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
|||
(1) |
Amount Previously Paid: |
|||
(2) | Form, Schedule or Registration Statement No.: |
|||
(3) | Filing Party: |
|||
(4) | Date Filed: |
|||
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
The Estée Lauder Companies Inc. 767 Fifth Avenue New York, New York 10153 |
||
William P. Lauder Executive Chairman |
||
September 27, 2018 |
Dear Fellow Stockholder:
You are cordially invited to attend the 2018 Annual Meeting of Stockholders. It will be held in New York City on Tuesday, November 13, 2018, at 10:00 a.m., local time, at the JW Marriott Essex House New York, where we will ask you to vote on the items set forth in the Notice of Annual Meeting of Stockholders below.
Please vote your shares using the Internet or telephone, or by requesting a printed copy of the proxy materials and completing and returning by mail the proxy card you receive in response to your request. Instructions on each of these voting methods are outlined in this Proxy Statement. Please vote as soon as possible.
Thank you for your continued support.
YOUR VOTE IS IMPORTANT. PLEASE PROMPTLY SUBMIT YOUR PROXY
BY INTERNET, TELEPHONE, OR MAIL.
THE
ESTÉE LAUDER COMPANIES INC.
767 Fifth Avenue
New York, New York 10153
Notice of Annual Meeting of Stockholders |
Tuesday, November 13, 2018
10:00 a.m., local time
JW Marriott Essex House New York
Grand Salon
160 Central Park South
New York, New York 10019
ITEMS OF BUSINESS:
We also will transact such other business as may properly come before the meeting and any adjournments or postponements of the meeting.
By Order of the Board of Directors |
||
SPENCER G. SMUL |
||
Senior Vice President, Deputy General Counsel and Secretary |
||
New York, New York September 27, 2018 |
THE BOARD OF DIRECTORS URGES YOU TO VOTE BY INTERNET OR BY TELEPHONE OR BY REQUESTING A PRINTED COPY OF THE PROXY MATERIALS AND COMPLETING AND RETURNING BY MAIL THE PROXY CARD YOU RECEIVE IN RESPONSE TO YOUR REQUEST.
IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE 2018 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON NOVEMBER 13, 2018: The Company's Proxy Statement for the 2018 Annual Meeting of Stockholders and the Annual Report to Stockholders for the fiscal year ended June 30, 2018 are available at www.envisionreports.com/EL.
Table of Contents |
Proxy Statement Summary |
This summary highlights information contained elsewhere in this Proxy Statement. This summary does not contain all the information that you should consider, and you should read the entire Proxy Statement before voting. The approximate date on which this Proxy Statement and form of proxy are first being provided to stockholders, or being made available through the Internet for those stockholders receiving their proxy materials electronically, is September 27, 2018.
2018 Annual Meeting of Stockholders
Date and Time: Record Date: |
| Tuesday, November 13, 2018 at 10:00 a.m. September 14, 2018 |
| Place: | | JW Marriott Essex House New York Grand Salon 160 Central Park South New York, New York 10019 |
Voting Matters
ITEMS OF BUSINESS | | BOARD RECOMMENDATION |
| PROXY STATEMENT DISCLOSURE |
||||
1 | | | | Election of Class I Directors | |
FOR each Director Nominee |
|
Page 8 |
| | | | |||||
2 | | | | Ratification of Appointment of KPMG LLP as Independent Auditors | | FOR | | Page 83 |
| | | | |||||
3 | | | | Advisory Vote to Approve Executive Compensation | | FOR | | Page 85 |
The following table provides information about the Class I Director Nominees standing for election to serve until the 2021 Annual Meeting of Stockholders. Information about all the Directors can be found in this Proxy Statement beginning on page 8.
Nominee | Current Position | Committee Membership | ||
Rose Marie Bravo | | Retail and Marketing Consultant | | Compensation Committee; and Stock Plan Subcommittee |
Paul J. Fribourg | | Chairman and Chief Executive Officer of Continental Grain Company | | Audit Committee; Compensation Committee; and Stock Plan Subcommittee |
Irvine O. Hockaday, Jr. | |
Former President and Chief Executive of Hallmark Cards, Inc. |
|
Nominating and Board Affairs Committee |
Jennifer Hyman | | Co-Founder and Chief Executive Officer of Rent the Runway, Inc. | | Audit Committee |
Barry S. Sternlicht | | Chairman and Chief Executive Officer of Starwood Capital Group | | Nominating and Board Affairs Committee |
| | |
|
|
2018 Proxy Statement | 1 |
As explained in the "Compensation Discussion and Analysis," we drive our annual and long-term performance through our executive compensation programs. Annual incentive pay is tied to business objectives that are specific to each individual's responsibilities and encourage collaboration across the organization. Long-term equity incentives are tied to both the Company's share price and financial goals over a period of three or more years. This combination of compensation elements is intended to support and promote strong, balanced, and sustainable corporate performance.
Fiscal 2018 was an outstanding year for our Company. We achieved record net sales and one of our best performances in the last decade. These results reflect, in part, the Company's strategy to drive growth by targeting its investments to shifts in consumer and market dynamics across product categories, geographic regions, brands, and distribution channels. This strategy positioned the Company well for the resurgence in global prestige skin care growth as well as the strong increase in demand among Chinese consumers. We generated higher sales in every region and product category and gained global share. By investing in our hero franchises, fast-growing channels, and digital and social media, we delivered double-digit sales and adjusted earnings per share growth as compared to the prior year.
Financial Measure |
Fiscal 2018 |
Change over Prior Year |
3-Year Compound Annual Growth Rate (or Basis Point Improvement) |
5-Year Compound Annual Growth Rate (or Basis Point Improvement) |
| ||||||||||||||
Net Sales |
| $ | 13.7 billion | | | 16% | | | | 8.3% | | | | 6.1% | | | |||
Net Sales as adjusted(1) |
| $ | 13.7 billion | | | 16% | | | | 7.7% | | | | 6.1% | | | |||
Net Sales as adjusted in constant currency(1) |
| $ | 13.4 billion | | | 13% | | | | N/A | | | | N/A | | | |||
Operating Margin |
| 15.0% | | | +70bp | | | | +10bp | | | | | | | ||||
Operating Margin as adjusted(1) |
| 16.6% | | | +70bp | | | | +70bp | | | | +140bp | | | ||||
Diluted EPS |
| $ | 2.95 | | | (12)% | | | | 1.5% | | | | 2.7% | | | |||
Diluted EPS as adjusted(1) |
| $ | 4.51 | | | 30% | | | | 13.7% | | | | 11.3% | | | |||
Diluted EPS as adjusted in constant currency(1) |
| $ | 4.31 | | | 24% | | | | N/A | | | | N/A | | | |||
Return on Invested Capital as adjusted(2) |
| 21.1% | | | +220bp | | | | 50bp | | | | 310bp | | | ||||
Cash Flow from Operations |
| $ | 2.6 billion | | | 43% | | | | 9.8% | | | | 16.0% | | | |||
Total Stockholder Return ("TSR") |
| 50.4% | | | | | | | 19.7% | | | | 18.2% | | | ||||
TSR S&P 500 Composite |
| 14.3% | | | | | | | 11.9% | | | | 13.4% | | |
| | |
2 | 2018 Proxy Statement |
|
|
foreign currency translation. See Appendix A for reconciliation and other information about these non-GAAP financial measures.
In fiscal 2018, we increased the common stock dividend 12%, repurchased 6 million shares of our Class A Common Stock for $759 million, and used $629 million of cash flow from operations for capital expenditures. Over the five-year period ended June 30, 2018, the total market value of the Company increased by over 100% or approximately $26 billion.
Executive Compensation Highlights
The following summarizes key executive compensation matters in connection with strong and sustained individual and company performance:
| | |
|
|
2018 Proxy Statement | 3 |
THE ESTÉE LAUDER COMPANIES INC.
767 Fifth Avenue
New York, New York 10153
PROXY STATEMENT
FOR ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD NOVEMBER 13, 2018
September 27, 2018
Annual Meeting and Voting
This Proxy Statement is furnished in connection with the solicitation of proxies on behalf of the Board of Directors of The Estée Lauder Companies Inc. (the "Company," "we," or "us"), a Delaware corporation, to be voted at the Annual Meeting of Stockholders to be held in the Grand Salon at the JW Marriott Essex House New York, 160 Central Park South, New York, New York, 10019 on Tuesday, November 13, 2018, at 10:00 a.m., local time, and at any adjournment or postponement of the meeting.
Admission to the meeting will require a ticket.
If you are a stockholder of record and plan to attend, please check the appropriate box on the proxy card, or so indicate when you vote by telephone or Internet, and an admission ticket will be mailed to you. If you want to attend the meeting, bring photo identification as well as your admission ticket. If you are a stockholder whose shares are held through an intermediary, such as a bank or broker, and you plan to attend, please request an admission ticket by writing to the Investor Relations Department at The Estée Lauder Companies Inc., 767 Fifth Avenue, New York, New York 10153. Evidence of your ownership of shares of our Common Stock on September 14, 2018 (the "Record Date"), which you can obtain from your bank, broker, or other intermediary, must accompany your letter.
Who may vote?
Only stockholders of record of shares of Class A Common Stock or Class B Common Stock at the close of business on the Record Date are entitled to vote at the Annual Meeting and at any adjournment or postponement of the meeting. Each owner of record of Class A Common Stock on the Record Date is entitled to one vote for each share of Class A Common Stock. Each owner of record of Class B Common Stock on the Record Date is entitled to ten votes for each share of Class B Common Stock. As of August 31, 2018, there were 223,485,801 shares of Class A Common Stock and 142,953,234 shares of Class B Common Stock issued and outstanding.
Why did I receive a notice in the mail regarding the Internet availability of the proxy materials instead of a paper copy of the proxy materials?
In accordance with rules of the Securities and Exchange Commission (the "SEC"), we have elected to furnish to our stockholders this Proxy Statement and our Fiscal 2018 Annual Report to Stockholders by providing access to these documents on the Internet rather than mailing printed copies. Accordingly, a Notice of Internet Availability of Proxy Materials (the "Notice") is being mailed to our stockholders of record and beneficial owners (other than those who previously requested printed copies or electronic delivery of our proxy materials), which will direct stockholders to a website where they can access our proxy materials and view instructions on how to vote online or by telephone. If you would prefer to receive a paper copy of our proxy materials, please follow the instructions included in the Notice.
| | |
4 | 2018 Proxy Statement |
|
|
How do I cast my vote if I am a stockholder of record?
If you are a stockholder of record (which means your shares are registered directly in your name with the Company's transfer agent, Computershare, Inc., or you have a physical stock certificate), you can vote your shares in one of two ways: either by proxy or in person at the Annual Meeting. If you choose to vote by proxy, you may do so by using the Internet or the telephone, or by requesting a printed copy of our proxy materials and completing and returning by mail the proxy card you receive in response to your request.
Whichever method you use, each valid proxy received in time will be voted at the Annual Meeting in accordance with your instructions. To ensure that your proxy is voted, it should be received before November 13, 2018. If you submit a proxy without giving instructions, your shares will be voted as recommended by the Board of Directors.
How do I cast my vote if my shares are held in "street name"?
If you are a beneficial owner of shares held in a stock brokerage account or by a bank or other nominee (i.e. in "street name"), you are invited to attend the Annual Meeting. However, since you are not a stockholder of record, you may not vote these shares in person at the Annual Meeting unless you bring with you a legal proxy from the stockholder of record. A legal proxy may be obtained from your broker, bank, or nominee.
If you do not wish to vote in person or you will not be attending the Annual Meeting, you may vote over the Internet or otherwise by following the instructions provided in the Notice, or, if you requested to receive printed proxy materials, you will receive voting instructions from your broker, bank, or nominee describing the available processes for voting your shares.
If your shares are held for you by a broker, your broker must vote those shares in accordance with your instructions. If you do not give voting instructions to your broker, your broker may vote your shares for you on any discretionary items of business to be voted upon at the Annual Meeting, i.e. the ratification of the appointment of KPMG LLP (Item 2).
Important Consideration for "street name" holders: You must instruct your broker if you want your shares to be counted in the election
of directors at the Annual Meeting (Item 1) and the advisory vote to
approve executive compensation (Item 3). New York Stock Exchange ("NYSE") rules prevent your broker from voting your shares on these matters without your instructions. Please follow the
instructions provided by your broker so that your vote can be counted.
May I change my vote?
All proxies delivered pursuant to this solicitation are revocable at any time before they are exercised, at the option of the persons submitting them, by giving written notice to the Secretary of the Company at the mailing address set forth below, by submitting a later-dated proxy (either by mail, telephone, or Internet) or by voting in person at the Annual Meeting. The mailing address of our principal executive offices is 767 Fifth Avenue, New York, New York 10153.
What constitutes a quorum?
The holders of a majority of the votes entitled to be cast by the stockholders entitled to vote generally, present in person or by proxy, shall constitute a quorum for the transaction of business at the Annual Meeting. Abstentions, broker non-votes, and votes withheld are included in the count to determine a quorum.
What if a quorum is not represented at the Annual Meeting?
In the event that a quorum does not exist, the Executive Chairman or the holders of a majority of the votes entitled to be cast by the stockholders who are present in person or by proxy may
| | |
|
|
2018 Proxy Statement | 5 |
adjourn the meeting whether or not a quorum is present. At a subsequent meeting at which a quorum is present, any business may be transacted that might have been transacted at the meeting as originally called.
How many votes are required to approve a proposal?
The following table notes for each proposal: (i) the vote required of Class A Common Stock and Class B Common Stock (voting together) for approval; (ii) whether abstentions count as votes cast; and (iii) whether broker discretionary voting is allowed.
Proposal | Vote required |
Do abstentions count as votes cast? |
Is broker discretionary voting allowed? |
|||
Item 1: Election of Class I Directors |
|
Plurality of Votes Cast* | | Not Applicable | | No |
Item 2: Ratify approval of KPMG LLP's appointment |
| Majority of Votes Cast | | No | | Yes |
Item 3: Advisory vote to approve Executive Compensation |
|
Majority of Votes Cast** | | No | | No |
Abstentions and broker non-votes do not count as votes cast, and therefore have no effect on vote outcomes.
How will my shares be voted?
All proxies properly submitted pursuant to this solicitation and not revoked will be voted at the Annual Meeting in accordance with the directions given. In the election of directors (Item 1), stockholders may vote in favor of, or withhold their votes from, each nominee. For the ratification of the appointment of KPMG LLP (Item 2) and the advisory vote to approve executive compensation (Item 3), stockholders may vote in favor of the proposal, may vote against the proposal, or may abstain from voting. Stockholders should specify their choices on the proxy card or pursuant to the instructions thereon for telephone or Internet voting. If no specific choices are indicated, the shares represented by a properly submitted proxy will be voted:
If you have returned your signed and completed proxy card, and other matters are properly presented at the Annual Meeting for consideration, the proxy holders appointed by the Board of
| | |
6 | 2018 Proxy Statement |
|
|
Directors (the persons named in your proxy card if you are a stockholder of record) will have the discretion to vote on those matters for you.
Who will count the vote?
Representatives of Computershare, Inc. will tabulate the votes and act as inspectors of election.
May I see a list of stockholders entitled to vote as of the Record Date?
A list of registered stockholders as of the close of business on the Record Date will be available for examination by any stockholder for any purpose germane to the Annual Meeting. This list will be available during such meeting and during normal business hours from October 30, 2018 through November 12, 2018, at the office of Spencer G. Smul, Senior Vice President, Deputy General Counsel and Secretary of the Company, at 767 Fifth Avenue, New York, New York 10153.
Can I access the Notice of Annual Meeting, Proxy Statement, Annual Report to Stockholders, and Form 10-K on the Internet?
Our Proxy Statement (including Notice of Annual Meeting) and Fiscal 2018 Annual Report to Stockholders are available at www.envisionreports.com/EL.
These materials are also available in the "Investors" section of our website at www.elcompanies.com. Instead of receiving future copies of our Proxy Statement (including Notice of Annual Meeting) and Annual Report by mail, stockholders can access these materials online. Opting to receive your proxy materials online will save us the cost of producing and mailing documents to you; an electronic link to the proxy voting site will be provided to you. Stockholders of record can enroll at www.computershare.com/investor for online access to future proxy materials.
If you hold your shares in a bank or brokerage account, you also may have the opportunity to receive copies of these documents electronically. Please check the information provided in the proxy materials mailed to you by your bank or broker regarding the availability of this service.
| | |
|
|
2018 Proxy Statement | 7 |
Election of Directors |
Board of Directors
Currently, the Board of Directors ("the Board") is comprised of seventeen directors. The directors are divided into three classes, each serving for a period of three years. Class I and Class II are each comprised of six directors, and Class III is comprised of five directors. As previously disclosed, Mellody Hobson, who is a Class I director, notified the Company that she will serve the remainder of her term, which expires at the 2018 Annual Meeting of Stockholders, and she will not stand for re-election. Ms. Hobson has been on the Board since 2005, and the Company is grateful for her valuable contributions. Following her departure as of November 13, 2018 (the date of our Annual Meeting), the Board will be comprised of sixteen directors, and Class I will be comprised of five directors.
The stockholders elect one class of the members of the Board of Directors annually. The directors whose terms will expire at the 2018 Annual Meeting of Stockholders are Rose Marie Bravo, Paul J. Fribourg, Mellody Hobson, Irvine O. Hockaday, Jr., Jennifer Hyman, and Barry S. Sternlicht. With the exception of Ms. Hobson, each of these directors has been nominated to stand for re-election as a Class I director at the 2018 Annual Meeting, to hold office until the 2021 Annual Meeting and until his or her successor is elected and qualified. In the unanticipated event that one or more of the nominees is unable or declines to serve for any reason, the Board may reduce the number of directors or take action to fill any vacancy.
Lauder Family Members, including related entities, who control the Company have agreed to vote their shares in favor of four individuals as directors: Jane Lauder, Leonard A. Lauder, Ronald S. Lauder and William P. Lauder. The term "Lauder Family Members" is defined below (see "Certain Relationships and Related Transactions Lauder Family Relationships and Compensation").
Director Qualifications. Our Board is comprised of individuals with diverse and complementary business
experience, leadership experience, and financial experience. Many of our directors
have leadership experience at major domestic and multinational companies, as well as experience on the boards of other companies and organizations, which provides an understanding of different
business processes, challenges, and strategies. Other directors have government, legal, public policy, or media experience that provides insight into issues faced by public companies. The members of
the Board are inquisitive and collaborative, challenging yet supportive, and demonstrate maturity and sound judgment in performing their duties. The Board believes that the above-mentioned attributes,
along with the leadership skills and other experience of its Board members, some of which are described in the biographies below, provide the appropriate perspectives and judgment to guide the
Company's long-term strategy, monitor progress, and oversee management.
The Company does not have a specific policy on diversity of the Board. Instead, the Board evaluates nominees in the context of the Board as a whole, with the objective of recommending a group that can best support the success of the business and, based on the group's diversity of experience, represent stockholder interests through the exercise of sound judgment. Such diversity of experience may be enhanced by a mix of different professional and personal backgrounds and experiences. The Company is proud to have a diverse board, including with respect to gender and race.
The Board recommends a vote FOR each nominee as a director to hold office until the 2021 Annual Meeting. Proxies received by the Board will be so voted unless a contrary choice is specified in the proxy. |
| | |
8 | 2018 Proxy Statement |
|
|
Nominees for Election to Term Expiring 2021 (Class I) |
Rose Marie Bravo, CBE | ||||
Committees: Compensation Committee and Stock Plan Subcommittee |
|
BACKGROUND Ms. Bravo is a retail and marketing consultant. She was Vice Chairman of Burberry Group plc from July 2006 to July 2007. Prior to that, she was Burberry's Chief Executive Officer from 1997 to July 2006. Prior to her appointment at Burberry, Ms. Bravo was President of Saks Fifth Avenue since 1992, with responsibility for merchandising, marketing, and product development. From 1974 to 1992, Ms. Bravo held a number of positions at R.H. Macy & Co., culminating as Chairman and Chief Executive Officer of the U.S. retailer I. Magnin from 1987 to 1992. Ms. Bravo is a member of the Board of Directors of Tiffany & Co. Additionally, within the past five years, she served as a director of Williams-Sonoma, Inc. |
|
QUALIFICATIONS
Global management, marketing, retail, and consumer and luxury brand industry experience as former Chief Executive Officer of Burberry, various leadership positions at Saks Fifth Avenue and Macy's, and in senior roles related to merchandising in the beauty category Board experience at Burberry, Tiffany & Co., and Williams-Sonoma, Inc. Experience working abroad Merchandise and product development expertise |
| | | | |
|
|
|||
Paul J. Fribourg | ||||
Committees: Audit Committee Compensation Committee and Stock Plan Subcommittee |
|
BACKGROUND Mr. Fribourg has been the Chairman and Chief Executive Officer of Continental Grain Company, an international agribusiness and investment company, since July 1997. He joined Continental Grain Company in 1976 and worked in various positions there with increasing responsibility in both the United States and Europe. Mr. Fribourg is on the boards of directors of Apollo Global Management, LLC, Loews Corporation, and Restaurant Brands International Inc. He also serves as a member of Rabobank's International North American Agribusiness Advisory Board, and as a board member and Executive Committee member of Castleton Commodities International LLC. He has been a member of the Council on Foreign Relations since 1985. |
|
QUALIFICATIONS
Global management, marketing, and other business experience as Chairman and Chief Executive Officer of Continental Grain Company Board experience at Apollo Global Management, LLC, Loews Corporation, and Restaurant Brands International Inc. Affiliation with leading business and public policy associations (Council on Foreign Relations) Financial experience |
| | | | |
| | |
|
|
2018 Proxy Statement | 9 |
Irvine O. Hockaday, Jr. | ||||
Presiding Director Committee: Nominating and Board Affairs Commitee (Chair) |
|
BACKGROUND Mr. Hockaday is the former President and Chief Executive Officer of Hallmark Cards, Inc. He retired in December 2001. Prior to joining Hallmark in 1983, he was President and Chief Executive Officer of Kansas City Southern Industries, Inc. Mr. Hockaday was a member of the Hallmark Board of Directors from 1978 until January 2002. He is currently a member of the Board of Directors of Aratana Therapeutics, Inc. Additionally, within the past five years, Mr. Hockaday served as a director of Crown Media Holdings, Inc. and Ford Motor Company. |
|
QUALIFICATIONS
Global business experience and consumer brand industry experience as former CEO of Hallmark Cards, Inc. Board experience at Aratana Therapeutics, Inc., Crown Media Holdings, Inc., Ford Motor Company, and Sprint Nextel Financial experience Legal experience |
| | | | |
|
|
|||
Jennifer Hyman | ||||
Committee: Audit Committee |
|
BACKGROUND Ms. Hyman is Co-founder and Chief Executive Officer of Rent the Runway, Inc., which rents designer apparel and accessories to women both on-demand and through its subscription service. Prior to co-founding Rent the Runway in November 2009, she was Director of Business Management at IMG, a global talent management company, from 2006 to 2007. Ms. Hyman was Senior Manager, Sales, at the WeddingChannel.com from 2005 to 2006. From 2002 to 2005, she was Senior Manager, Leisure Program Development at Starwood Hotels & Resorts Worldwide, Inc. |
|
QUALIFICATIONS
Management and entrepreneurial experience as Co-founder and Chief Executive Officer of Rent the Runway, Inc. Deep knowledge about millennials and other consumers Omnichannel and social-digital experience Board experience at Rent the Runway, Inc. Financial experience |
| | | | |
| | |
10 | 2018 Proxy Statement |
|
|
Barry S. Sternlicht | ||||
Committee: Nominating and Board Affairs Committee |
|
BACKGROUND Mr. Sternlicht is Chairman and Chief Executive Officer of Starwood Capital Group, a privately-held global investment firm with a primary focus on global real estate, which he formed in 1991. He also serves as Chairman and CEO of Starwood Property Trust, Inc., a commercial mortgage REIT. Mr. Sternlicht is on the boards of directors of Invitation Homes, Inc., Starwood Real Estate Income Trust, and A.S. Roma. He is also Chairman of the Board of Baccarat S.A. Additionally, within the past five years, Mr. Sternlicht served as a director of Restoration Hardware Holdings, Inc., Riviera Holdings Corporation, and TRI Pointe Group, Inc. From 1995 through early 2005, Mr. Sternlicht was Chairman and CEO of Starwood Hotels & Resorts Worldwide, Inc., a company he founded in 1995. He currently serves as a member of the board of The Robin Hood Foundation, and he is on the board of the Dreamland Film & Performing Arts Center and the Executive Advisory Board of Americans for the Arts. |
|
QUALIFICATIONS
Global business, investment, real estate, financial, private equity, entrepreneurial, and consumer brand and luxury industry expertise at Starwood Capital Group, as Chairman of Starwood Property Trust, Inc., and as founder and former Chief Executive of Starwood Hotels & Resorts Worldwide, Inc. Board experience at A.S. Roma, Baccarat S.A., Invitation Homes, Inc., Restoration Hardware Holdings, Inc., Starwood Property Trust, Inc., and TRI Pointe Group, Inc. Financial experience |
| | | | |
Incumbent Directors Term Expiring 2019 (Class II) |
Ronald S. Lauder | ||||
|
|
BACKGROUND Mr. Lauder has served as Chairman of Clinique Laboratories, LLC since returning from government service in 1987 and was Chairman of Estee Lauder International, Inc. from 1987 through 2002. Mr. Lauder joined the Company in 1964 and has served in various capacities. Mr. Lauder was a member of the Board of Directors of the Company from 1968 to 1986 and again from 1988 to July 2009. From 1983 to 1986, he served as Deputy Assistant Secretary of Defense for European and NATO Affairs. From 1986 to 1987, he was U.S. Ambassador to Austria. Mr. Lauder is an Honorary Chairman of the Board of Trustees of the Museum of Modern Art and President of the Neue Galerie. Within the past five years, Mr. Lauder served as a director of Central European Media Enterprises Ltd. He is also Chairman of the Board of Governors of the Joseph H. Lauder Institute of Management and International Studies at The Wharton School at the University of Pennsylvania and the co-founder and Co-Chairman of the Alzheimer's Drug Discovery Foundation. |
|
QUALIFICATIONS
Global business, marketing, and consumer and luxury brand industry experience through leadership roles at The Estée Lauder Companies Inc. Affiliation with leading business, civic, and government associations Board experience at Central European Media Enterprises Ltd. Significant stockholder and party to Stockholders' Agreement |
| | | | |
| | |
|
|
2018 Proxy Statement | 11 |
William P. Lauder | ||||
Committee: Nominating and Board Affairs Committee |
|
BACKGROUND Mr. Lauder is Executive Chairman of the Company and, in such role, he is Chairman of the Board of Directors. He was Chief Executive Officer of the Company from March 2008 through June 2009 and President and Chief Executive Officer from July 2004 through February 2008. From January 2003 through June 2004, he was Chief Operating Officer. From July 2001 through 2002, Mr. Lauder was Group President, responsible for the worldwide business of the Clinique and Origins brands and the Company's retail store and online operations. From 1998 to 2001, he was President of Clinique Laboratories, LLC. Prior to 1998, he was President of Origins Natural Resources Inc., and he had been the senior officer of that division since its inception in 1990. Prior thereto, he served in various positions since joining the Company in 1986. Within the past five years, Mr. Lauder served as a director of Jarden Corporation. He currently serves as Chairman of the Board of the Fresh Air Fund and as a member of the boards of trustees of the University of Pennsylvania and The Trinity School in New York City, a member of the boards of directors of the 92nd Street Y and the Partnership for New York City, and is on the Advisory Board of Zelnick Media. Mr. Lauder is also Co-Chairman of the Breast Cancer Research Foundation. |
|
QUALIFICATIONS
Global business, marketing, Internet, retail, and consumer and luxury brand industry experience through leadership roles at The Estée Lauder Companies Inc. Experience leading successful creative organizations with innovation programs based on research and development Board experience at GLG Partners, Inc., Jarden Corporation, and True Temper Sports, Inc. Trustee of the University of Pennsylvania and lecturer at The Wharton School Financial experience Significant stockholder and party to Stockholders' Agreement |
| | | | |
|
|
|||
Richard D. Parsons | ||||
Committees: Compensation Committee Nominating and Board Affairs Committee |
|
BACKGROUND Mr. Parsons has been a senior advisor to Providence Equity Partners LLC, a global private equity and investment firm, since 2009. From 1996 until 2012, he was a director of Citigroup Inc. and served as its Chairman from February 2009 to April 2012. From May 2003 until his retirement in December 2008, Mr. Parsons served as Chairman of the Board of Time Warner Inc. From May 2002 until December 2007, he served as Chief Executive Officer of Time Warner Inc. From January 2001 until May 2002, Mr. Parsons was Co-Chief Operating Officer of AOL Time Warner. From 1995 until the merger with America On-Line Inc., he was President of Time Warner Inc. From 1990 through 1994, he was Chairman and Chief Executive Officer of Dime Bancorp, Inc. Mr. Parsons is currently on the boards of directors of CBS Corporation, Lazard Ltd., and The Madison Square Garden Company. Among his numerous community activities, he is Chairman of the Apollo Theatre Foundation and the Jazz Foundation of America. |
|
QUALIFICATIONS
Global business, marketing, media, Internet, banking, and other business and consumer brand experience through leadership roles at Time Warner Inc. and Dime Bancorp, Inc. Board experience at CBS Corporation, Citigroup Inc., Lazard Ltd., The Madison Square Garden Company, and Time Warner Inc. Private equity experience at Providence Equity Partners LLC Legal and government experience Financial experience |
| | | | |
| | |
12 | 2018 Proxy Statement |
|
|
Lynn Forester de Rothschild | ||||
Committee: Nominating and Board Affairs Committee |
|
BACKGROUND Lady de Rothschild is the Chair of E.L. Rothschild LLC, a private investment company with investments in media, information technology, agriculture, financial services, and real estate worldwide, and she was the Chief Executive of E.L. Rothschild LLC from 2002 to 2016. Holdings of E.L. Rothschild LLC include The Economist Group (UK). Lady de Rothschild has been a director of The Economist Newspaper Limited since October 2002. From 2004 to 2007, she was also Co-Chair of FieldFresh Pvt. Ltd., a 50-50 joint venture with Bharti Enterprises, established to develop the agricultural sector in India. From 1989 to 2002, she was President and Chief Executive Officer of FirstMark Holdings, Inc., which owned various telecommunications companies worldwide. She serves on the Board and Executive Committee of The Peterson Institute for International Economics. Lady de Rothschild is a trustee of the Eranda Foundation and a board member of the International Advisory Board of Columbia University School of Law and the Alzheimer Drug Discovery Foundation. She is a member of the Council on Foreign Relations (USA), Chatham House (UK), the International Advisory Council of Asia House (UK), the International Institute of Strategic Studies (UK), and the Foreign Policy Association (USA). |
|
QUALIFICATIONS
Global business and investment experience as former Chief Executive of E.L. Rothschild LLC and CEO of FirstMark Holdings, Inc. Board and media experience as director of The Economist Newspaper Limited Affiliation with leading business and public policy associations (Council on Foreign Relations) Experience working abroad Legal and government expertise Financial experience |
| | | | |
|
|
|||
Jennifer Tejada | ||||
Committee: Audit Committee |
|
BACKGROUND Ms. Tejada is Chief Executive Officer of PagerDuty, Inc., a digital operations management platform for businesses. Prior to joining PagerDuty in July 2016, she was President and Chief Executive Officer of Keynote Systems, a software company specializing in digital performance analytics and web and mobile testing, from 2013 to 2015. Ms. Tejada was Executive Vice President and Chief Strategy Officer of Mincom, an enterprise software company, from 2008 to 2011. She has also previously held senior positions at Merivale Group, Procter & Gamble, and i2 Technologies. She currently serves as a member of the board of Puppet Labs, Inc., a private IT automation company. |
|
QUALIFICATIONS
Management experience at PagerDuty, Inc., Keynote Systems, and Mincom. Digital, mobile, cyber and software experience Consumer goods experience Experience working abroad Board experience at PagerDuty, Inc., Keynote Systems, and Puppet Labs, Inc. Financial experience |
| | | | |
| | |
|
|
2018 Proxy Statement | 13 |
Richard F. Zannino | ||||
Committee: Audit Committee (Chair) |
|
BACKGROUND Mr. Zannino is a Managing Director at the private equity firm CCMP Capital Advisors, LLC, a position he has held since July 2009. He is a partner on the firm's Investment Committee and co-heads the consumer retail practice. Prior to joining CCMP Capital, Mr. Zannino was an independent retail and media advisor from February 2008 to June 2009. He was Chief Executive Officer and a member of the Board of Directors of Dow Jones & Company, Inc. from February 2006 until January 2008, shortly after its acquisition by News Corp. Mr. Zannino joined Dow Jones as Executive Vice President and Chief Financial Officer in February 2001 and was promoted to Chief Operating Officer in July 2002. From 1998 to 2001, he was Executive Vice President of Liz Claiborne, Inc., where he oversaw the finance, administration, retail, fragrance, and licensing divisions. From 1993 to 1998, Mr. Zannino was with Saks Fifth Avenue, serving as Vice President and Treasurer, Senior Vice President, Finance and Merchandise Planning, and then Executive Vice President and Chief Financial Officer. He is on the boards of directors of IAC/InterActiveCorp and Ollie's Bargain Outlet Holdings, Inc. Additionally, within the past five years, Mr. Zannino served as a director of Francesca's Holdings Corporation. He currently serves as Vice Chairman of the Board of Trustees of Pace University. |
|
QUALIFICATIONS
Management, media, finance, retail, and consumer brand industry experience in various positions at Dow Jones & Company, Inc., Liz Claiborne, Inc., and Saks Fifth Avenue Consumer, retail, media, and private equity experience at CCMP Capital Advisors, LLC Board experience at Dow Jones & Company, Inc., Francesca's Holdings Corporation, IAC/InterActiveCorp, and Ollie's Bargain Outlet Holdings, Inc. Trustee of Pace University Financial experience |
| | | | |
Incumbent Directors Term Expiring 2020 (Class III) |
Charlene Barshefsky | ||||
Committees: Compensation Committee (Chair) and Stock Plan Subcommittee |
|
BACKGROUND Ambassador Barshefsky is Senior International Partner at the law firm of WilmerHale in Washington, D.C. Prior to joining the law firm in 2001, she was the United States Trade Representative from 1997 to 2001, and Deputy United States Trade Representative and Acting United States Trade Representative from 1993 to 1996. Ambassador Barshefsky is a member of the Board of Directors of American Express Company. Additionally, within the past five years, she served as a director of Intel Corporation and Starwood Hotels & Resorts Worldwide, Inc. Ambassador Barshefsky is a member of the Council on Foreign Relations and a trustee of the Howard Hughes Medical Institute. |
|
QUALIFICATIONS
International, government, and public policy experience as United States Trade Representative Legal experience, including current role as Senior International Partner at WilmerHale Board experience at American Express Company, Intel Corporation, and Starwood Hotels & Resorts Worldwide, Inc. Trustee of the Howard Hughes Medical Institute |
| | | | |
| | |
14 | 2018 Proxy Statement |
|
|
Wei Sun Christianson | ||||
Committee: Nominating and Board Affairs Committee |
|
BACKGROUND Ms. Christianson is a Managing Director and Co-Chief Executive Officer of Asia Pacific and Chief Executive Officer of China at Morgan Stanley based in Beijing. In addition to her regional role, Ms. Christianson is responsible for all aspects of Morgan Stanley's operations in China and is a member of Morgan Stanley's Management Committee. Prior to rejoining Morgan Stanley in 2006, she was the Chairman of China for Citigroup Global Markets (Asia Ltd.) and previously served as Chairman of China and Country Manager for Credit Suisse First Boston. Ms. Christianson held an earlier position at Morgan Stanley beginning in 1998 as Executive Director and Beijing Representative. She is a member of the Advisory Committee of the Securities and Futures Commission of Hong Kong and the Financial Services Development Council of Hong Kong. |
|
QUALIFICATIONS
Global management and investment banking experience as Managing Director and Co-Chief Executive Officer of Asia Pacific and Chief Executive Officer of China at Morgan Stanley based in Beijing Experience working abroad, particularly in China Financial experience Government experience (in Hong Kong) |
| | | | |
|
|
|||
Fabrizio Freda | ||||
|
|
BACKGROUND Mr. Freda has served as President and Chief Executive Officer of the Company since July 2009. From March 2008 through June 2009, he was President and Chief Operating Officer where he oversaw the Clinique, Bobbi Brown, La Mer, Jo Malone London, Aveda, and Bumble and bumble brands, and the Aramis and Designer Fragrances division. He also was responsible for the Company's International Division, as well as Global Operations, Research and Development, Packaging, Quality Assurance, Merchandise Design, Corporate Store Design, and Retail Store Operations. Prior to joining the Company, Mr. Freda served in a number of positions of increasing responsibility at The Procter & Gamble Company ("P&G"), where he was responsible for various operating, marketing, and key strategic efforts for over 20 years. From 2001 through 2007, Mr. Freda was President, Global Snacks, at P&G. He also spent more than a decade in the Health and Beauty Care division at P&G. From 1986 to 1988, Mr. Freda directed marketing and strategic planning for Gucci SpA. He is currently a member of the Board of Directors of BlackRock, Inc., a global asset management company. |
|
QUALIFICATIONS
Global management, marketing, and other business, consumer and luxury brand industry experience as President and Chief Executive Officer of The Estée Lauder Companies Inc. Similar experience, including developing and leading global organizations, in leadership positions at P&G and Gucci SpA Experience leading successful, creative organizations with innovation programs based on research and development Board experience at BlackRock, Inc. Experience living and working in several countries Financial experience |
| | | | |
| | |
|
|
2018 Proxy Statement | 15 |
Jane Lauder | ||||
|
|
BACKGROUND Ms. Lauder has served as Global Brand President, Clinique, since April 2014. Immediately prior to that, she was Global President, General Manager of the Origins, Ojon, and Darphin brands. From July 2008 until July 2010, she was Senior Vice President/General Manager of the Origins brand. Ms. Lauder began her career with the Company in 1996 at Clinique and served in various positions throughout the Company until July 2006, when she became Senior Vice President, Global Marketing for Clinique. |
|
QUALIFICATIONS
Management, marketing and other industry experience through leadership roles at The Estée Lauder Companies Inc. Significant stockholder and party to Stockholders' Agreement (solely as trustee of one or more trusts) |
| | | | |
|
|
|||
Leonard A. Lauder | ||||
|
|
BACKGROUND Mr. Lauder is Chairman Emeritus of the Company. He was Chairman of the Board of Directors from 1995 through June 2009 and served as the Company's Chief Executive Officer from 1982 through 1999 and President from 1972 until 1995. Mr. Lauder has held various positions since formally joining the Company in 1958 after serving as an officer in the United States Navy. He is Chairman Emeritus of the Board of Trustees of the Whitney Museum of American Art, a Charter Trustee of the University of Pennsylvania, a Trustee of The Aspen Institute, and the co-founder and Co-Chairman of the Alzheimer's Drug Discovery Foundation. Mr. Lauder is Honorary Chairman of the Breast Cancer Research Foundation. He served as a member of the White House Advisory Committee on Trade Policy and Negotiations under President Reagan. |
|
QUALIFICATIONS
Global business, marketing, and consumer and luxury brand industry experience through leadership roles at The Estée Lauder Companies Inc. Experience leading successful creative organizations with innovation programs based on research and development Affiliation with leading business, civic, and public policy associations Charter Trustee of the University of Pennsylvania Significant stockholder and party to Stockholders' Agreement |
| | | | |
| | |
16 | 2018 Proxy Statement |
|
|
Additional Information Regarding the Board of Directors
Stockholders' Agreement and Lauder Family Control. All Lauder Family Members who are party to a stockholders' agreement with the Company (the "Stockholders' Agreement") have agreed to vote shares beneficially owned by them for Leonard A. Lauder (or for one of his sons), Ronald S. Lauder (or for one of his daughters), and one person, if any, designated by each as a director of the Company. Aerin Lauder and Jane Lauder are parties to the Stockholders' Agreement solely as trustees of certain trusts. The term "Lauder Family Members" is defined below (see "Certain Relationships and Related Transactions Lauder Family Relationships and Compensation"). Shares subject to the Stockholders' Agreement represent approximately 85% of the voting power of the Company as of the Record Date. The right of each of Leonard A. Lauder (or his sons) and Ronald S. Lauder (or his daughters) to designate a nominee exists only when he (including his descendants) beneficially owns (other than by reason of the Stockholders' Agreement) shares of Common Stock with at least 10% of the total voting power of the Company. Currently, William P. Lauder is the nominee of Leonard A. Lauder, and Jane Lauder is the nominee of Ronald S. Lauder. The right of each of Leonard A. Lauder (or one of his sons) and Ronald S. Lauder (or one of his daughters) to be nominated will exist so long as he (including his descendants) beneficially owns shares of Common Stock with at least 5% of the total voting power of the Company. In the event that Leonard A. Lauder ceases to be a member of the Board of Directors by reason of his death or disability, then his sons, William P. Lauder and Gary M. Lauder, will succeed to his rights to be nominated as a director and to designate one nominee. If either son is unable to serve by reason of his death or disability, the other son will have the right to designate a nominee. Similarly, Aerin Lauder and Jane Lauder, Ronald S. Lauder's daughters, will succeed to their father's rights upon his death or disability. If either daughter is unable to serve by reason of her death or disability, the other daughter will have the right to designate a nominee. In the event none of Leonard A. Lauder and his sons and Ronald S. Lauder and his daughters are able to serve as directors by reason of death or disability, then the rights under the Stockholders' Agreement to be a nominee and to designate a nominee will cease. The Stockholders' Agreement will terminate upon the occurrence of certain specified events, including the transfer of shares of Common Stock by a party to the Stockholders' Agreement that causes all parties thereto immediately after such transaction to own beneficially in the aggregate shares having less than 10% of the total voting power of the Company.
The Lauder family has direct and indirect holdings of approximately 87% of the voting power of the Company as of the Record Date. The Company is a "controlled company" under the rules of the New York Stock Exchange (the "NYSE") because the Lauder family and their related entities hold more than 50% of the voting power of the outstanding voting stock. As such, the Company may avail itself of exemptions relating to the Board and certain Board committees. Despite the availability of such exemptions, the Board of Directors has determined that it will have a majority of independent directors and that both the Nominating and Board Affairs Committee and the Compensation Committee will have otherwise required provisions in their charters. As permitted by the NYSE rules for "controlled companies," our Board does not require that the Nominating and Board Affairs Committee and the Compensation Committee be comprised solely of independent directors.
Board Committees. The Board of Directors has established the following standing committees the Audit Committee, the
Compensation Committee (which includes the
Stock Plan Subcommittee), and the Nominating and Board Affairs Committee. Each director on these committees is an independent director except for William P. Lauder and Richard D.
Parsons. Each committee reports regularly to the Board and has the authority to engage its own advisors. From time to time, the Board considers the composition of our Board committees. In April 2018,
Ms. Hyman and Ms. Tejada joined the Audit Committee when they were elected to the Board. In early fiscal 2019, Mr. Hockaday left the Audit Committee, and Mr. Zannino became
Chair of the Audit Committee; Ambassador Barshefsky joined the Compensation Committee and the Stock Plan Subcommittee and became Chair of the Compensation Committee, and Mr. Zannino left the
Compensation Committee and the Stock Plan Subcommittee; and Mr. Hockaday joined the Nominating and Board Affairs Committee as Chair, and Ms. Barshefsky left the Nominating and Board
Affairs Committee.
| | |
|
|
2018 Proxy Statement | 17 |
The members of the committees as of the Record Date are set forth in the following table:
Director |
Audit Committee |
Compensation Committee |
Nominating and Board Affairs Committee |
|||
Charlene Barshefsky | | | | | | |
Rose Marie Bravo | | | | |||
Wei Sun Christianson | | | | | | |
Paul J. Fribourg | | | | |||
Mellody Hobson | | | | | | |
Jennifer Hyman | | | | |||
Irvine O. Hockaday, Jr.* | | | | | | |
William P. Lauder | | | | |||
Richard D. Parsons | | | | | ||
Lynn Forester de Rothschild | | | | |||
Barry S. Sternlicht | | | | | | |
Jennifer Tejada | | | | |||
Richard F. Zannino | | | | | |
Chair Member
Copies of the charters adopted by the Board of Directors for each committee may be found in the "Investors" section of the Company's website, www.elcompanies.com, under "Corporate Governance."
Audit | Richard F. Zannino (Chair) |
Jennifer Hyman |
||
Committee | Paul J. Fribourg |
Jennifer Tejada |
||
Mellody Hobson |
The Audit Committee, among other things, appoints the independent auditors; reviews the independence of such auditors; approves the scope of the annual audit activities of the independent auditors and the Company's Internal Control Department; reviews audit results; reviews and discusses the Company's financial statements with management and the independent auditors; reviews and discusses with the Board the Company's risk assessment and management processes; and is responsible for our related person transactions policy. The committee also meets separately, at least quarterly, with the Chief Financial Officer, the Chief Internal Control Officer, and representatives of the independent auditors. The Board of Directors has determined that each of Mr. Fribourg, Ms. Hobson, and Mr. Zannino qualifies as an "Audit Committee Financial Expert" in accordance with SEC rules. As previously noted, Ms. Hobson is not standing for re-election at the 2018 Annual Meeting; therefore, as of November 13, 2018, she will no longer be on the Audit Committee.
| | |
18 | 2018 Proxy Statement |
|
|
Compensation | Charlene Barshefsky (Chair) |
Paul J. Fribourg |
||
Committee | Rose Marie Bravo |
Richard D. Parsons |
The Compensation Committee establishes and approves compensation plans and arrangements with respect to the Company's executive officers and administers the Company's Executive Annual Incentive Plan. The Stock Plan Subcommittee has authority over all decisions regarding awards to executive officers under the Company's share incentive plans and authority to administer the Company's share incentive plans under which executive officers and other employees may receive equity grants. The Company also has an Employee Equity Award Committee, the sole member of which is Mr. Freda; the purpose of this committee is to make limited grants of equity awards under the share incentive plan to employees who are not executive officers, and the committee made such grants in fiscal 2018.
Compensation Committee Interlocks and Insider Participation. During fiscal 2018, Ms. Bravo, Mr. Fribourg, Mr. Parsons,
and Mr. Zannino served on the Compensation Committee. None of these
directors is a former or current officer or employee of the Company or any of its subsidiaries. During fiscal 2018, none of our executive officers served as a member of the compensation committee (or
other committee performing similar functions) or as a director of any other entity of which an executive officer served on our Board or Compensation Committee. None of the directors who served on our
Compensation Committee during fiscal 2018 has any relationship requiring disclosure under this caption under SEC rules.
Nominating and | Irvine O. Hockaday, Jr. (Chair) |
Richard D. Parsons |
||
Board Affairs | Wei Sun Christianson |
Lynn Forester de Rothschild |
||
Committee | William P. Lauder |
Barry S. Sternlicht |
The Nominating and Board Affairs Committee, among other things, recommends nominees for election as members of the Board; considers and makes recommendations regarding Board practices and procedures; considers corporate governance issues that arise from time to time and develops appropriate recommendations for the Board regarding such matters; and reviews the compensation for service as a Board member.
Board and Board Committee Meetings; Annual Meeting Attendance; and Executive Sessions. Directors are expected to devote sufficient time
to carrying out their duties and responsibilities effectively, and should be committed to serve on the Board for
an extended period of time. In furtherance of the Board's role, directors are expected to attend all scheduled Board and Board committee meetings and all meetings of stockholders. In fiscal 2018, the
Board of Directors met five times, the Compensation Committee met five times, the Stock Plan Subcommittee met six times, the Audit Committee met eight times, and the Nominating and Board Affairs
Committee met three times. The total combined attendance for all Board and committee meetings was over 95%. No director attended less than 75% of Board and committee meetings. The non-employee
directors met five times in executive session in fiscal 2018, including at least one meeting at which only independent directors were present. Directors are expected to attend the Annual Meeting of
Stockholders, and all of the directors who were on the Board attended the Annual Meeting of Stockholders in November 2017, except one director who was unable to attend.
Board Leadership Structure. Our Board is currently led by our Executive Chairman, who is a member of the Lauder family. Our President
and Chief Executive Officer is a member of our Board of
Directors. We have an independent director who serves as our Presiding Director. A majority of our directors are independent. At present, there are 17 directors on our Board; 12 directors are
non-employee directors, 11 directors are independent, and 4 directors are members of the Lauder family. As previously noted, Mellody Hobson is not standing for re-election at the 2018 Annual
| | |
|
|
2018 Proxy Statement | 19 |
Meeting; therefore, as of November 13, 2018, the Board will be comprised of sixteen directors. The Presiding Director presides at all meetings or executive sessions of non-employee or independent directors. The Board of Directors considers this structure appropriate in view of the Lauder family's significant investment in the Company. The structure also comports with the Stockholders' Agreement among various members of the Lauder family and the Company. See "Additional Information Regarding the Board of Directors Stockholders' Agreement and Lauder Family Control."
In addition to his responsibilities as Chairman of the Board, Mr. W. Lauder, as Executive Chairman, works with the President and Chief Executive Officer to set overall vision, strategy, financial objectives, and investment priorities for the business. Mr. W. Lauder also continues to provide high-level leadership in areas that are important to the Company, including marketing, trade relations, global communications, and regulatory affairs.
As provided in our Corporate Governance Guidelines, we have an independent director who serves as our Presiding Director. The Presiding Director serves a one-year term beginning with the meeting of the Board immediately following the Annual Meeting of Stockholders and is selected from among the independent members of the Board. Mr. Hockaday served as the Presiding Director for all executive sessions of the Board of Directors in fiscal 2018, and he has been appointed by the Board to serve for an additional one-year term beginning after the 2018 Annual Meeting.
Board Role in Risk Oversight. Our Board of Directors regularly receives reports from our President and Chief Executive Officer and other
members of senior management regarding areas of
significant risk to us, including strategic, operational, financial, legal and regulatory, cybersecurity, and reputational risks. However, senior management is responsible for assessing and managing
the Company's various risk exposures on a day-to-day basis. In this regard, various management functions within the Company, such as Legal, Finance, Treasury, Internal Control, Information Technology,
Global Supply Chain, Research & Development, and Environmental Affairs and Safety, focus on particular risks. Management has a systemic and integrated approach to overall risk management that
includes the identification of risks and mitigation plans in the strategic planning process. The Board's role is one of oversight, assessing major risks facing the Company and reviewing options for
their mitigation with management. In addition, the Audit Committee reviews and discusses with management our enterprise risk management processes.
Risk in Compensation Programs. The Company has a framework for evaluating incentive plan design features that may encourage or help
mitigate risk, such as a mix of compensation elements,
metrics, leverage, caps, and time horizons, in order to determine whether the risks arising from our compensation programs (in addition to those applicable only to executive officers) are reasonably
likely to have a material adverse effect on the Company. Using this framework in fiscal 2018, we concluded that our compensation programs are not reasonably likely to have a material adverse effect on
the Company. The results were reviewed with senior management and the Compensation Committee.
Board Membership Criteria. The Nominating and Board Affairs Committee works with the Board on an annual basis to determine the
appropriate characteristics, skills, and experience for the
Board as a whole and its individual members. All directors should possess the highest personal and professional ethics as well as an inquisitive and objective perspective, practical wisdom, and mature
judgment. In evaluating the suitability of individual Board members, the Board takes into account many factors, including general understanding of marketing, finance, and other disciplines relevant to
the success of a large publicly traded company in today's business environment; understanding of the Company's business on a technical level; and educational and professional background. The Board
evaluates each individual in the context of the Board as a whole, with the objective of recommending a group that can best support the success of the business and, based on its diversity of
experience, represent stockholder interests through the exercise of sound judgment. In determining whether to recommend a director for re-election, the Nominating and Board Affairs
| | |
20 | 2018 Proxy Statement |
|
|
Committee also considers the director's past attendance at meetings and participation in and contributions to the activities of the Board.
Upon determining the need for a new director candidate, the Nominating and Board Affairs Committee will identify one or more director candidates and evaluate each candidate under the criteria described above based on the information it receives with a recommendation or that it otherwise possesses, which information may be supplemented by additional inquiries. Application of these criteria involves the exercise of judgment and cannot be measured in any mathematical or routine way. Based on its assessment of each candidate's independence, skills, and qualifications and the criteria described above, the Committee will make recommendations regarding potential director candidates to the Board. The Committee may engage third parties to assist in the search for director candidates or to assist in gathering information regarding a candidate's background and experience. The Committee will evaluate stockholder-recommended candidates in the same manner as other candidates. Candidates may also be designated pursuant to the Stockholders' Agreement. See "Additional Information Regarding the Board of Directors Stockholders' Agreement and Lauder Family Control." Jennifer Hyman and Jennifer Tejada were recommended for consideration as director candidates by an independent non-management director, and in accordance with the process described above, both candidates were evaluated by the Nominating and Board Affairs Committee. In April 2018, at the recommendation of the Nominating and Board Affairs Committee, the Board elected Ms. Hyman as a Class I director (to stand for re-election at the 2018 Annual Meeting) and Ms. Tejada as a Class II director (to stand for re-election at the 2019 Annual Meeting).
Board Independence Standards for Directors. To be considered "independent" for purposes of membership on the Company's Board of
Directors, the Board must determine that a director has no material
relationship with the Company, including any of its subsidiaries, other than as a director. For each director, the Board broadly considers all relevant facts and circumstances. In making its
determination, the Board considers the following categories of relationships to be material, thus precluding a determination that a director is "independent:"
| | |
|
|
2018 Proxy Statement | 21 |
Additionally, the following relationships will not be considered to be "material" relationships that would impair a director's independence:
Contributions to tax exempt organizations shall not be considered payments for purposes of these independence standards. An "immediate family member" includes a director's spouse, parents, children, siblings, mothers- and fathers-in-law, sons- and daughters-in-law, brothers-and sisters-in-law, and anyone (other than domestic employees) who shares such person's home.
The Board reviews at least annually whether directors meet these Director Independence Standards. The following directors, including all of the directors nominated for election, have been determined by the Board to be "independent" pursuant to NYSE rules and the Company's Independent Director Standards described above: Charlene Barshefsky, Rose Marie Bravo, Wei Sun Christianson, Paul J. Fribourg, Mellody Hobson, Irvine O. Hockaday, Jr., Jennifer Hyman, Lynn Forester de Rothschild, Barry S. Sternlicht, Jennifer Tejada and Richard F. Zannino.
In addition to the foregoing, in order to be considered "independent" under NYSE rules for purposes of serving on the Company's Audit Committee or Compensation Committee, a director also may not accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the Company, other than as a director, and may not be an "affiliated person" of the Company. Audit Committee members may receive directors' fees and fixed payments for prior service with the Company. The Board has determined that each member of the Audit Committee and each independent member of the Compensation Committee meets these additional independence requirements.
Communications with the Board. A stockholder or any other interested party who wishes to communicate with the Board, any Committee
thereof, the non-management directors as a group, or any
individual director, including the Presiding Director for the executive sessions of the Board, may do so by addressing the correspondence to that individual or group, c/o Sara E. Moss,
Executive Vice President and General Counsel, The Estée Lauder Companies Inc., 767 Fifth Avenue, New York, New York 10153. The General Counsel or a designee will review all such
correspondence to determine if the substance of the correspondence relates to the duties and responsibilities of the Board or individual Board member before forwarding the correspondence to the
intended recipient. Spam, junk mail, solicitations, and hostile, threatening, illegal, or similarly unsuitable material will not be forwarded to the intended recipient and, if circumstances warrant,
may be forwarded to the Company's security staff. Any communication that is not forwarded may be made available to the intended recipient at his or her request.
Director Nominees Recommended by Stockholders. The Nominating and Board Affairs Committee will consider stockholder recommendations of
nominees in the same manner as and pursuant to the same criteria by which
it considers all other nominees, except for nominations received pursuant to the Stockholders' Agreement. Stockholders who wish to suggest qualified candidates should send their written recommendation
to the Nominating and Board Affairs Committee, c/o Sara E. Moss, Executive Vice President and General Counsel, The Estée Lauder Companies Inc., 767 Fifth Avenue, New York,
New York 10153. The following information must accompany any such recommendation by a stockholder: (i) the name and address of the stockholder making the recommendation; (ii) the name,
address, telephone number, and social security number of the proposed nominee; (iii) the class or series and number of shares of the Company that are beneficially owned by the stockholder
making the recommendation; (iv) a description of all
| | |
22 | 2018 Proxy Statement |
|
|
arrangements or understandings between the stockholder and the candidate, and an executed written consent of the proposed nominee to serve as a director of the Company if so elected; (v) a copy of the proposed nominee's resume and references; and (vi) an analysis of the candidate's qualifications to serve on the Board of Directors and on each of the Board's committees in light of the criteria for Board membership established by the Board. See "Board Membership Criteria." For stockholders intending to nominate an individual for election as a director directly, there are specific procedures set forth in our bylaws. See "Stockholder Proposals and Director Nominations for the 2019 Annual Meeting" below.
Corporate Governance Guidelines and Code of Conduct
The Board of Directors has developed corporate governance practices to help it fulfill its responsibilities to stockholders in providing general direction and oversight of management of the Company. These practices are set forth in the Company's Corporate Governance Guidelines. The Company also has a Code of Conduct (the "Code") applicable to all employees, officers, and directors of the Company including the Chief Executive Officer and the Chief Financial Officer. These documents, as well as any waiver of a provision of the Code granted to any senior officer or director or any material amendment to the Code, may be found in the "Investors" section of the Company's website: www.elcompanies.com under "Corporate Governance."
Section 16(a) Beneficial Ownership Reporting Compliance
Section 16(a) of the Securities Exchange Act of 1934 requires the Company's officers and directors, and any persons who own more than 10% of the Class A Common Stock, to file forms reporting their initial beneficial ownership of Common Stock and subsequent changes in that ownership with the SEC and the NYSE. Officers, directors, and greater-than-10% beneficial owners also are required to furnish the Company with copies of all forms they file under Section 16(a). Based solely upon a review of the copies of the forms furnished to the Company, or a written representation from a reporting person that no Form 5 was required, the Company believes that during fiscal 2018, all Section 16(a) reports were filed on a timely basis, except for one late filing on behalf of John Demsey, an executive officer, for one transaction.
Related Person Transactions Policy and Procedures
We have a written policy (the "Related Person Transactions Policy") that sets forth procedures for the review, approval, and ratification of transactions involving "Related Persons." Such persons consist of any director, director nominee, executive officer, any beneficial owner of more than 5% of the Company's Common Stock, any immediate family member of such persons, and any other person deemed to be a Related Person under the rules of the SEC. Under the Related Person Transactions Policy, a "Transaction" includes any financial transaction, arrangement, or relationship (including any indebtedness or guarantee of indebtedness) or any series of similar transactions, arrangements, or relationships where the Company and a Related Person are participants. The Audit Committee is responsible for administering this policy.
When a potential Related Person Transaction is identified, our policy requires that it be promptly reported to either the General Counsel or the Secretary to review. If it is determined that such Transaction is not within the scope of the Related Person Transactions Policy, then no further action is necessary. Otherwise, the Transaction shall be presented to the Audit Committee to make an assessment and determination. The information presented to the Audit Committee in connection with its assessment may include the following: (i) the Related Person's relationship to the Company; (ii) a description of the Transaction, including the material terms, the approximate aggregate value, and the identities of other parties; (iii) the benefits of the Transaction to the Company and the Related Person; (iv) the availability of other sources of comparable products or services; and (v) any other relevant information. If the Audit Committee determines that the Related Person has a direct or indirect material interest in any Transaction, the Transaction shall be disclosed in the Company's proxy statement. If the Related Person at issue is a director of the
| | |
|
|
2018 Proxy Statement | 23 |
Company, or an immediate family member of a director, then such director shall not participate in the assessment or determination of the Transaction being reviewed.
Certain Relationships and Related Transactions
Lauder Family Relationships and Compensation. Leonard A. Lauder is Chairman Emeritus, and his brother Ronald S. Lauder is Chairman of Clinique Laboratories, LLC. Leonard A. Lauder and Ronald S. Lauder are also directors of the Company. Leonard A. Lauder has two sons, William P. Lauder and Gary M. Lauder. William P. Lauder is Executive Chairman and in such role is Chairman of the Board of Directors. Gary M. Lauder is not an employee of the Company. Ronald S. Lauder and his wife, Jo Carole Lauder, have two daughters, Aerin Lauder and Jane Lauder. Aerin Lauder is not an employee of the Company. She is the Style and Image Director for the Estée Lauder brand (see "Agreements with Aerin Lauder" below for additional information). Jane Lauder is Global Brand President, Clinique and is a director of the Company.
For fiscal 2018, the following Lauder Family Members received the following amounts from the Company as compensation: Leonard A. Lauder received an aggregate of $1,800,000 for his services (comprised of base salary); Ronald S. Lauder received $650,000 in salary and a bonus of $491,400; and Jane Lauder received $780,000 in salary, a bonus of $878,000, performance share units with a target payout of 3,935 shares of Class A Common Stock, stock options for 15,644 shares of Class A Common Stock, and restricted stock units for 3,935 shares of Class A Common Stock. Each of these Lauder Family Members is entitled to participate in standard benefit plans, such as the Company's pension and medical plans. For information regarding fiscal 2018 compensation for William P. Lauder, see "Executive Compensation."
For fiscal 2019, Leonard A. Lauder has a base salary of $1,800,000, and Ronald S. Lauder has a base salary of $650,000 and bonus opportunities with a target payout of $350,000. For fiscal 2019, Jane Lauder has a base salary of $810,000, a target incentive bonus opportunity of $670,000, and a target equity opportunity of $1,075,000. In September 2018, Jane Lauder was granted equity-based compensation with an aggregate value of approximately $1.25 million, comprised of performance share units with a target payout of 3,009 shares of Class A Common Stock, stock options for 10,052 shares of Class A Common Stock, and restricted stock units for 3,009 shares of Class A Common Stock, in each case for fiscal 2019. The grants were consistent with those made to employees at her level. For information regarding fiscal 2019 compensation for William P. Lauder, see "Compensation Discussion and Analysis."
Leonard A. Lauder's current employment agreement (the "LAL Agreement") provides for his employment as Chairman Emeritus until such time as he resigns, retires, or is terminated. Mr. L. Lauder is entitled to participate in standard benefit plans, such as the Company's pension and medical plans. He is also entitled to participate in the Amended and Restated Fiscal 2002 Share Incentive Plan, but no grants have been made to him under the plan to date. If Mr. L. Lauder retires, the Company will continue to provide him with the office he currently occupies (or a comparable office if the Company relocates) and a full-time executive assistant. The Company may terminate Mr. L. Lauder's employment at any time if he becomes "permanently disabled," in which event he will be entitled to (i) receive his base salary for a period of two years after termination, (ii) receive bonus compensation during such salary continuation period at an annual rate equal to the average of the actual bonuses paid to him prior to such termination under the LAL Agreement (the "Leonard Lauder Bonus Compensation"), and (iii) participate in the Company's benefit plans for two years. In the event of Mr. L. Lauder's death during the term of his employment, for a period of one year from the date of Mr. L. Lauder's death, his beneficiary or legal representative will be entitled to receive Mr. L. Lauder's base salary and the Leonard Lauder Bonus Compensation. Mr. L. Lauder may terminate his employment at any time upon six months' written notice to the Company, in which event he will be entitled to receive his base salary and the Leonard Lauder Bonus Compensation for the six-month period following termination. In addition, the Company may terminate Mr. L. Lauder's employment for any reason upon 60 days' written notice. In the event of termination of his employment by the Company (other than for cause, disability, or death) or a termination by
| | |
24 | 2018 Proxy Statement |
|
|
Mr. L. Lauder for good reason after a change of control, (a) Mr. L. Lauder, for a period of three years from the date of termination, will be entitled to (i) receive his base salary in effect at the time of termination, (ii) receive the Leonard Lauder Bonus Compensation, (iii) participate in the Company's benefit plans and (b) in the case of termination by the Company (other than for cause, disability, or death), Mr. L. Lauder will not be subject to the non-competition covenant contained in the LAL Agreement. Upon termination for any reason, any options previously granted to Mr. L. Lauder will remain exercisable for the remainder of their respective terms, subject to certain non-competition and good conduct provisions.
As used in this Proxy Statement, the term "Lauder Family Members" includes only the following persons: (i) the estate of Mrs. Estée Lauder; (ii) each descendant of Mrs. Lauder (a "Lauder Descendant") and their respective estates, guardians, conservators, or committees; (iii) each "Family Controlled Entity" (as defined below); and (iv) the trustees, in their respective capacities as such, of each "Family Controlled Trust" (as defined below). The term "Family Controlled Entity" means: (i) any not-for-profit corporation if at least 80% of its board of directors is composed of Lauder Descendants; (ii) any other corporation if at least 80% of the value of its outstanding equity is owned by Lauder Family Members; (iii) any partnership if at least 80% of the value of its partnership interests are owned by Lauder Family Members; and (iv) any limited liability or similar company if at least 80% of the value of the company is owned by Lauder Family Members. The term "Family Controlled Trust" includes certain trusts existing on November 16, 1995 and trusts the primary beneficiaries of which are Lauder Descendants, spouses of Lauder Descendants, and/or charitable organizations, provided that if the trust is a wholly charitable trust, at least 80% of the trustees of such trust consist of Lauder Descendants.
Registration Rights Agreement. Leonard A. Lauder, Ronald S. Lauder, The Estée Lauder 1994 Trust, William P. Lauder,
Gary M. Lauder, Aerin Lauder,
Jane Lauder, certain Family Controlled Entities and other Family Controlled Trusts, Morgan Guaranty Trust Company of New York ("Morgan Guaranty"), and the Company are parties to a Registration Rights
Agreement (the "Registration Rights Agreement"), pursuant to which each of Leonard A. Lauder, Ronald S. Lauder, and Morgan Guaranty has three demand registration rights and The
Estée Lauder 1994 Trust has six demand registration rights in respect of shares of Class A Common Stock (including Class A Common Stock issued upon conversion of
Class B Common Stock) held by them. Three of the demand rights granted to The Estée Lauder 1994 Trust may be used only by a pledgee of The Estée Lauder 1994
Trust's shares of Common Stock. All the parties to the Registration Rights Agreement (other than the Company) also have an unlimited number of piggyback registration rights in respect of their
shares. The rights of Morgan Guaranty and any other pledgee of The Estée Lauder 1994 Trust under the Registration Rights Agreement will be exercisable only in the event of a default
under certain loan arrangements. Leonard A. Lauder and Ronald S. Lauder may assign their demand registration rights to Lauder Family Members. The Company is not required to effect more
than one registration of Class A Common Stock in any consecutive twelve-month period. The piggyback registration rights allow the holders to include their shares of Class A Common Stock
in any registration statement filed by the Company, subject to certain limitations.
The Company is required to pay all expenses (other than underwriting discounts and commissions of the selling stockholders, taxes payable by the selling stockholders, and the fees and expenses of the selling stockholders' counsel) in connection with any demand registrations, as well as any registrations pursuant to the exercise of piggyback rights. The Company has agreed to indemnify the selling stockholders against certain liabilities, including liabilities arising under the Securities Act of 1933.
| | |
|
|
2018 Proxy Statement | 25 |
Stockholders' Agreement. All Lauder Family Members who are party to the Stockholders' Agreement have agreed to vote shares beneficially
owned by them for Leonard A. Lauder (or for
one of his sons), Ronald S. Lauder (or for one of his daughters), and one person, if any, designated by each as a director of the Company. Aerin Lauder and Jane Lauder are parties to the
Stockholders' Agreement solely as trustees of certain trusts. Shares subject to the Stockholders' Agreement represent a substantial majority of the voting power of the Company as of the Record Date.
See "Additional Information Regarding the Board of Directors Stockholders' Agreement and Lauder Family Control."
Parties to the Stockholders' Agreement may, without restriction under the agreement, sell their shares in a widely distributed underwritten public offering, in sales made in compliance with Rule 144 under the Securities Act of 1933 or to other Lauder Family Members. In addition, each party to the Stockholders' Agreement may freely donate shares in an amount not to exceed 1% of the outstanding shares of Common Stock in any 90-day period. In the case of other private sales, each stockholder who is a party to the Stockholders' Agreement (the "Offering Stockholder") has granted to each other party (the "Offeree") a right of first offer to purchase shares of Class A Common Stock that the Offering Stockholder intends to sell to a person (or group of persons) who is not a Lauder Family Member. Each Offeree has the opportunity to purchase the Offeree's pro rata portion of the shares to be offered by the Offering Stockholder, as well as additional shares not purchased by other Offerees. Any shares not purchased pursuant to the right of first offer may be sold at or above 95% of the price offered to the Offerees. The Stockholders' Agreement also includes provisions for bona fide pledges of shares of Common Stock and procedures related to such pledges. The Stockholders' Agreement will terminate upon the occurrence of certain specified events, including the transfer of shares of Common Stock by a party to the Stockholders' Agreement that causes all parties thereto immediately after such transaction to own beneficially in the aggregate shares having less than 10% of the total voting power of the Company.
Agreements with Aerin Lauder. Estee Lauder Inc. ("ELI"), a subsidiary of the Company, is party to (i) a creative consultant
agreement with Aerin Lauder (the "Creative Consultant
Agreement") and (ii) a brand license agreement with Ms. Lauder and Aerin LLC, a limited liability company wholly owned by Ms. Lauder (the "License Agreement").
Under the Creative Consultant Agreement, Aerin Lauder is a spokesperson for the Estée Lauder brand and collaborates with the Estée Lauder Creative Director on creative aspects of the brand as Style and Image Director. The current term of this agreement expires June 30, 2021. For fiscal 2018, Ms. Lauder received approximately $604,500 for her services under the agreement. For fiscal 2019, she will receive approximately $628,600 for such services. During the term of the Creative Consulting Agreement, the Company has the exclusive right to use Ms. Lauder's name and image to market beauty products and related services of the Estée Lauder brand, and Ms. Lauder has agreed to no more than 25 days of personal appearances per year for the brand, the Company, or its subsidiaries, after which ELI is required to pay her an additional amount per day (for fiscal 2018, $26,000; and for fiscal 2019, $27,000). No additional amount per day was paid in fiscal 2018. In addition, an office and access to an assistant are provided to Ms. Lauder in connection with her services.
Separately, in fiscal 2017, the Company agreed to make payments totaling $500,000 to Aerin LLC in each of fiscal 2017 through and including fiscal 2021 in connection with brand-building activities for AERIN Beauty and the AERIN lifestyle brand, provided that the then current Aerin LLC management remained in place. The Company made such payments in fiscal 2017 (totaling $500,000) and in fiscal 2018 (totaling $333,330). The lower amount in fiscal 2018 reflected changes in Aerin LLC management.
Under the License Agreement, Aerin LLC has granted ELI a worldwide license to use the "Aerin" trademark and "A" logo (and related marks) and Ms. Lauder's name and image (i) exclusively in connection with "Core Beauty Products" (cosmetics, fragrances, toiletries, skin care, hair care, value sets, and beauty accessories) and (ii) non-exclusively in connection with "Non-Core Beauty Products"
| | |
26 | 2018 Proxy Statement |
|
|
(cosmetics bags, tote bags, and fragranced candles). The License Agreement covers the name "Aerin" and not the name "Lauder," for which the Company and its subsidiaries retain sole ownership. The initial license term expired on June 30, 2017, at which time the agreement automatically renewed for an additional 5-year period through June 30, 2022. The License Agreement provides for two additional 5-year renewal terms if ELI does not give notice of non-renewal and net sales hit certain performance targets (or if ELI cures a sales shortfall, in certain circumstances).
Under the License Agreement, Aerin LLC will receive the following royalties: (i) for all products other than fragrances, 4% of annual net sales up to $40 million and 5% of annual net sales in excess thereof; and (ii) for fragrances, 5% of annual net sales. For fiscal 2018, Aerin LLC was paid approximately $607,600 in royalties. Under the agreement, ELI must spend the following minimum amounts to promote Aerin-branded products: 15% of ELI's net sales each annual period (June 30 July 1) in the remaining term of the agreement, with such requirement capped each year at 50% of Aerin LLC's similar expenditures, either directly or through other licensees, on Aerin-branded products. Both ELI and Aerin LLC will distribute Aerin-branded products only through prestige retailers. In addition, in fiscal 2018, in connection with the License Agreement, the Company received approximately $112,000 from Aerin LLC for AERIN products provided for sale in Aerin retail locations and on Aerin LLC's website.
ELI launched AERIN Beauty in September 2012 with several products, and additional products have been introduced since then. ELI may launch additional AERIN-branded products in its reasonable commercial judgment. Under the License Agreement, Ms. Lauder has agreed to provide at least ten personal appearances during each fiscal year, for which she will not be compensated, and which are in addition to those appearances covered by the Creative Consultant Agreement. ELI will be responsible for Ms. Lauder's reasonable travel expenses in connection with such appearances. Aerin LLC may terminate the License Agreement if an unaffiliated third party obtains more than 50% of the voting power or equity of ELI. ELI may terminate the License Agreement if control of Aerin LLC (or substantially all of its assets) is transferred to a competitor of ELI or to certain categories of retailers not engaged in prestige distribution. Either side may terminate the License Agreement for an uncured material breach.
Other Arrangements. The Company has subleased certain of its office space in New York to an affiliate of Ronald S. Lauder. For fiscal
2018, the rent paid or accrued was approximately
$911,900, which equals the Company's lease payments for that space. The Company also has agreed to provide such affiliate with certain services, such as phone systems, payroll service, and office and
administrative services, which are reimbursed at a rate approximating the Company's incremental cost thereof. For fiscal 2018, such affiliate paid approximately $13.2 million pursuant to such
agreement. At June 30, 2018, such affiliate had deposited with the Company approximately $2.0 million to cover expenses. The Company has similar arrangements for space and services with
an affiliate of Leonard A. Lauder and his family. For fiscal 2018, that affiliate and/or family member(s) paid the Company approximately $7.76 million for office space and certain
services, such as phone systems, payroll service, and office and administrative services. At June 30, 2018, that affiliate and family members had deposited with the Company approximately
$297,600 to cover expenses. The payments by the affiliates and family members approximated the Company's incremental cost of the relevant space and services.
Certain members of the Lauder family (and entities affiliated with one or more of them) own numerous works of art that are displayed at the Company's offices. The Company pays no fee to the owners for displaying such works. The owners of the works pay for their maintenance. In fiscal 2018, the Company paid premiums of less than $10,000 for insurance relating to such works.
| | |
|
|
2018 Proxy Statement | 27 |
Director Compensation |
The following summary describes compensation for non-employee directors.
Annual Cash Retainer for Board Service. Each non-employee director receives an annual cash retainer of $100,000, payable quarterly,
which may be deferred as explained below.
Annual Cash Retainer for Presiding Director. The Presiding Director receives an additional annual cash retainer of $30,000, payable
quarterly, which may be deferred as explained below.
Annual Cash Retainer for Committee Service. Each non-employee director who serves on a committee receives an additional annual cash
retainer in the following amounts: $12,000 per year for service on the
Audit Committee, $8,000 per year for service on the Compensation Committee (including service on the Stock Plan Subcommittee), and $8,000 per year for service on the Nominating and Board Affairs
Committee. The Chair of the Audit Committee receives a further annual cash retainer of $25,000. The Chairs of the Compensation Committee and the Nominating and Board Affairs Committee receive a
further annual cash retainer of $15,000 each. Cash retainers for committee service are paid quarterly and may be deferred, as explained below.
Deferral of Annual Cash Retainers. Non-employee directors may elect to defer receipt of all or part of their cash-based compensation.
Specifically, pursuant to Deferred Compensation Agreements,
they may defer any or all of the above-referenced annual cash retainers into either (i) stock units (accompanied by dividend equivalent rights) or (ii) an interest-bearing cash account,
in each case to be paid out in a lump sum in cash as of the first business day of the calendar year following the date on which the director ceases to be a member of the Board.
Initial Stock Grant. On the date of the first annual meeting of stockholders that is more than six months after a non-employee
director's initial election to the Board, the director
receives a grant of 2,000 shares of Class A Common Stock (plus a cash payment in an amount to cover related income taxes), pursuant to the Amended and Restated Non-Employee Director Share
Incentive Plan (the "Director Share Plan").
Annual Stock Units Retainer for Board Service. An additional $75,000 is payable to each non-employee director by a grant of stock units
(accompanied by dividend equivalent rights) as an annual stock retainer,
pursuant to the Director Share Plan. This grant is made on the date of each annual meeting of stockholders. The number of stock units to be awarded is determined by dividing $75,000 by the average
closing price of the Class A Common Stock on the twenty trading days preceding the date of grant. Each stock unit is convertible into one share of Class A Common Stock, and the
Class A Common Stock represented by the stock units is distributed to the director on or after the first business day of the calendar year following the date on which the director ceases to be
a member of the Board.
Annual Stock Options. In addition to the cash and stock portion of the retainer, each non-employee director receives an annual grant of
options valued at no more than $100,000 on the
date of grant, pursuant to the Director Share Plan. This grant is made on the date of each annual meeting of stockholders. The exercise price of the options is equal to the closing price of the
Class A Common Stock on the date of grant. The options are exercisable beginning one year after the date of grant, provided that the director continues to serve as of such date. The options
generally terminate ten years after the date of grant.
Stock Ownership Requirement. As set forth in the Company's Corporate Governance Guidelines, the Board believes that in order to align
the interests of directors and stockholders, directors
should have a significant financial stake in the Company. Specifically, each director should own shares of the Company's Common Stock with a value equal to or greater than four times the annual cash
retainer for Board service. Applying this guideline for fiscal 2018, each director was
| | |
28 | 2018 Proxy Statement |
|
|
required to own shares of the Company's Common Stock with a value equal to or greater than $400,000 (i.e. $100,000 × 4). A director must be in compliance with this requirement no later than three years after initial election to the Board. Therefore, Ms. Hyman and Ms. Tejada have until April 2021 to satisfy this requirement. As of the end of fiscal 2018, each of the other directors was in compliance with this stock ownership requirement.
Company Products. The Company provides directors with certain Company products from different brands and product categories. The Company
believes that providing these products
serves a business purpose by expanding the directors' knowledge of the Company's business. The Company also provides each non-employee director with the opportunity to purchase up to $1,280 worth of
the Company's products each calendar year (based on suggested retail prices) at no charge; if a director chooses to take advantage of this opportunity and purchase more than $640 worth of the
Company's products, the excess is imputed as taxable income to the director. For the year ended June 30, 2018, the aggregate incremental cost to the Company for products provided to the
directors was substantially less than $10,000 per director. Non-employee directors may also purchase Company products at a price equal to 50% off the suggested retail price, which is the same discount
made available to officers and other employees of the Company.
Reimbursement of Expenses. Non-employee directors are reimbursed for their reasonable expenses (including costs of travel, food, and
lodging) incurred in attending Board, committee, and
stockholder meetings. Directors are also reimbursed for any other reasonable expenses relating to their service on the Board, including participating in director continuing education and Company site
visits.
Management Directors. Directors who are also employees of the Company receive no additional compensation for service as directors. These
directors are Fabrizio Freda, Jane Lauder,
Leonard A. Lauder, Ronald S. Lauder, and William P. Lauder.
The following table sets forth compensation information regarding the Company's non-employee directors in fiscal 2018.
Name |
Fees Earned or Paid in Cash ($)(1) |
Stock Awards ($)(2)(3) |
Option Awards ($)(4)(5) |
Non-Equity Incentive Plan Compensation ($) |
Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)(6) |
All Other Compensation ($) |
Total ($) |
| ||||||||||||||||||||
Charlene Barshefsky |
| $ | 101,750 | | $ | 74,999 | | $ | 99,966 | | | | | | | $ | 24,037 | | | | | | | $ | 300,752 | | ||
Rose Marie Bravo |
| 101,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 276,715 | | |||||||
Wei Sun Christianson |
| 101,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 276,715 | | |||||||
Paul J. Fribourg |
| 113,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 288,715 | | |||||||
Mellody Hobson |
| 105,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 280,715 | | |||||||
Irvine O. Hockaday, Jr. |
| 160,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 335,715 | | |||||||
Jennifer Hyman* |
| 28,000 | | | | | | | | | | | | | | | | | | 28,000 | | |||||||
Richard D. Parsons |
| 124,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 299,715 | | |||||||
Lynn Forester de Rothschild |
| 116,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 291,715 | | |||||||
Barry S. Sternlicht |
| 101,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 276,715 | | |||||||
Jennifer Tejada* |
| 28,000 | | | | | | | | | | | | | | | | | | 28,000 | | |||||||
Richard F. Zannino |
| 113,750 | | 74,999 | | 99,966 | | | | | | | | | | | | | | 288,715 | |
| | |
|
|
2018 Proxy Statement | 29 |
Name |
Total Number of Shares of Class A Common Stock Underlying Stock Awards Outstanding as of June 30, 2018 |
|||||
Charlene Barshefsky |
| | 17,395 | | | |
Rose Marie Bravo |
| | 13,842 | | | |
Wei Sun Christianson |
| | 7,568 | | | |
Paul J. Fribourg |
| | 9,142 | | | |
Mellody Hobson |
| | 15,770 | | | |
Irvine O. Hockaday, Jr. |
| | 20,974 | | | |
Jennifer Hyman* |
| | 0 | | | |
Richard D. Parsons |
| | 16,363 | ** | | |
Lynn Forester de Rothschild |
| | 17,177 | | | |
Barry S. Sternlicht |
| | 12,917 | | | |
Jennifer Tejada* |
| | 0 | | | |
Richard F. Zannino |
| | 8,381 | | |
| | |
30 | 2018 Proxy Statement |
|
|
Name |
Total Number of Shares of Class A Common Stock Underlying Stock Options Outstanding as of June 30, 2018 |
|||||
Charlene Barshefsky |
| | 59,074 | ** | | |
Rose Marie Bravo |
| | 19,762 | | | |
Wei Sun Christianson |
| | 29,074 | | | |
Paul J. Fribourg |
| | 19,762 | | | |
Mellody Hobson |
| | 49,074 | | | |
Irvine O. Hockaday, Jr. |
| | 15,949 | | | |
Jennifer Hyman* |
| | 0 | | | |
Richard D. Parsons |
| | 19,762 | | | |
Lynn Forester de Rothschild |
| | 49,074 | | | |
Barry S. Sternlicht |
| | 66,752 | | | |
Jennifer Tejada* |
| | 0 | | | |
Richard F. Zannino |
| | 19,762 | | |
| | |
|
|
2018 Proxy Statement | 31 |
Ownership of Shares
The following table sets forth certain information regarding the beneficial ownership of the Company's Class A Common Stock and Class B Common Stock as of August 6, 2018 by: (i) each person known by the Company to own beneficially more than 5% of the outstanding shares of either Class A Common Stock or Class B Common Stock; (ii) each of the Company's directors or nominees; (iii) each of the current or former executive officers whose names appear in the Summary Compensation Table; and (iv) all current directors and executive officers as a group. Except as set forth in the notes to the table, the business or mailing address of each 5% stockholder is 767 Fifth Avenue, New York, New York 10153. As described in the notes to the table, certain named beneficial owners share voting and/or investment power with respect to certain shares of Common Stock. Consequently, such shares are shown as beneficially owned by more than one person.
|
|
Class A Common Stock(1) |
Class B Common Stock |
Voting Power |
||||||||||||
| | | | | | | | | | | | |||||
Name of Beneficial Owner |
Number(2) | % | Number | % | % | |||||||||||
Leonard A. Lauder(3)(4) |
| 1,527,838 | | 0.7 | % | | | | | * | | |||||
LAL Family Corporation(3)(5) |
| | | | | 88,859,684 | | 62.1 | % | 53.7 | % | |||||
Ronald S. Lauder(3)(6) |
| 73,335 | | * | | 9,409,895 | | 6.6 | % | 5.7 | % | |||||
William P. Lauder(3)(7) |
| 422,056 | | 0.2 | % | 8,093,904 | | 5.7 | % | 4.9 | % | |||||
Gary M. Lauder(3)(8) |
| 10,468 | | * | | 45,740 | | * | | * | | |||||
Aerin Lauder(3)(9) |
| 1,692 | | * | | 6,585,594 | | 4.6 | % | 4.0 | % | |||||
Jane Lauder(3)(10) |
| 195,466 | | * | | 5,185,594 | | 3.6 | % | 3.1 | % | |||||
Joel S. Ehrenkranz, as trustee(3)(11) |
| 1,507,838 | | 0.7 | % | | | | | * | | |||||
Richard D. Parsons, individually and |
|
37,661 | | * | | 29,781,862 | | 20.8 | % | 18.0 | % | |||||
Charlene Barshefsky(13) |
| 117,568 | | * | | | | | | * | | |||||
Rose Marie Bravo(14) |
| 38,698 | | * | | | | | | * | | |||||
Wei Sun Christianson(15) |
| 37,795 | | * | | | | | | * | | |||||
Paul J. Fribourg(16) |
| 29,998 | | * | | | | | | * | | |||||
Mellody Hobson(17) |
| 231,161 | | 0.1 | % | | | | | * | | |||||
Irvine O. Hockaday, Jr.(18) |
| 50,757 | | * | | | | | | * | | |||||
Jennifer Hyman(19) |
| | | | | | | | | | | |||||
Lynn Forester de Rothschild(20) |
| 67,345 | | * | | | | | | * | | |||||
Barry S. Sternlicht(21) |
| 143,745 | | * | | | | | | * | | |||||
Jennifer Tejada(22) |
| | | | | | | | | | | |||||
Richard F. Zannino(23) |
| 25,237 | | * | | | | | | * | | |||||
Fabrizio Freda(24) |
| 1,067,293 | | 0.5 | % | | | | | * | | |||||
John Demsey(25) |
| | | | | | | | | | | |||||
Cedric Prouvé(26) |
| 236,181 | | 0.1 | % | | | | | * | | |||||
Tracey T. Travis(27) |
| 272,732 | | 0.1 | % | | | | | * | | |||||
BlackRock, Inc.(28) |
| 15,790,395 | | 7.0 | % | | | | | 1.0 | % | |||||
FMR LLC(29) |
| 17,263,713 | | 7.7 | % | | | | | 1.0 | % | |||||
The Vanguard Group(30) |
| 16,073,929 | | 7.2 | % | | | | | 1.0 | % | |||||
All directors and executive officers |
| 4,950,836 | | 2.2 | % | 54,146,255 | | 37.9 | % | 33.0 | % |
| | |
32 | 2018 Proxy Statement |
|
|
| | |
|
|
2018 Proxy Statement | 33 |
Mr. R. Lauder disclaims beneficial ownership of the shares of Class A Common Stock and Class B Common Stock owned by trusts for the benefit of one or more of his children and by the Ronald S. Lauder Foundation. 7,375,000 shares of Class B Common Stock are pledged by Mr. R. Lauder to secure loans under loan facilities with certain banks as to which he has sole voting power and shares investment power with certain pledgees under the loan facilities; and 2,000,000 shares of Class B Common Stock are pledged to secure his obligations under a prepaid variable forward sale contract to an unaffiliated third-party buyer and with respect to which he has sole voting power and shares investment power with such third-party buyer.
Mr. W. Lauder disclaims beneficial ownership of shares held by the trust to the extent he does not have a pecuniary interest in such shares.
Mr. G. Lauder disclaims beneficial ownership of the shares to the extent he does not have a pecuniary interest in such shares.
Ms. A .. Lauder disclaims beneficial ownership to the extent that she does not have a pecuniary interest in the shares held by the trust. Shares held by Ms. A. Lauder directly are not subject to the Stockholders' Agreement. Richard D. Parsons is trustee of a trust for the benefit of Ms. A. Lauder that holds shares of Class B Common Stock. See note (12).
Ms. J. Lauder
disclaims beneficial ownership to the extent that she does not have a pecuniary interest in the shares held by the trust. Shares held by
Ms. J. Lauder directly are not subject to
the Stockholders' Agreement. Richard D. Parsons is trustee of a trust for the benefit of Ms. J. Lauder that holds shares of Class B Common Stock. See note (12).
| | |
34 | 2018 Proxy Statement |
|
|
disclaims beneficial ownership of all such shares. Mr. Ehrenkranz's business address is 375 Park Avenue, New York, New York 10152.
The 4202 Trust owns all of the outstanding shares of The 4202 Corporation, which corporation is a Lauder Family Member and owns the shares of Class B Common Stock directly. The 4202 Corporation is not a party to the Stockholders' Agreement; therefore any shares of Class A and Class B Common Stock owned by The 4202 Corporation are not subject to that agreement. Mr. Parsons disclaims beneficial ownership of the shares held by The 4202 Corporation. Mr. Parsons's business address is 9 West 57th Street, Suite 4700, New York, New York 10019.
| | |
|
|
2018 Proxy Statement | 35 |
| | |
36 | 2018 Proxy Statement |
|
|
| | |
|
|
2018 Proxy Statement | 37 |
Executive Compensation
Compensation Discussion and Analysis
Executive Summary
We drive our annual and long-term performance through our executive compensation programs. Annual incentive pay is tied to business objectives that are specific to each individual's responsibilities and encourage collaboration across the organization. Long-term equity incentives are tied to both the Company's share price and financial goals over a period of three or more years. As explained below, this combination of compensation elements is intended to support and promote strong, balanced, and sustainable corporate performance.
Fiscal 2018 was an outstanding year for our Company. We achieved record net sales and one of our best performances in the last decade. These results reflect, in part, the Company's strategy to drive growth by targeting its investments to shifts in consumer and market dynamics across product categories, geographic regions, brands, and distribution channels. This strategy positioned the Company well for the resurgence in global prestige skin care growth as well as the strong increase in demand among Chinese consumers. We generated higher sales in every region and product category and gained global share. By investing in our hero franchises, fast-growing channels, and digital and social media, we delivered double-digit sales and adjusted earnings per share growth as compared to the prior year.
Financial Measure |
Fiscal 2018 |
Change over Prior Year |
3-Year Compound Annual Growth Rate (or Basis Point Improvement) |
5-Year Compound Annual Growth Rate (or Basis Point Improvement) |
| ||||||||||||||
Net Sales |
| $ | 13.7 billion | | | 16% | | | | 8.3% | | | | 6.1% | | | |||
Net Sales as adjusted(1) |
| $ | 13.7 billion | | | 16% | | | | 7.7% | | | | 6.1% | | | |||
Net Sales as adjusted in constant currency(1) |
| $ | 13.4 billion | | | 13% | | | | N/A | | | | N/A | | | |||
Operating Margin |
| 15.0% | | | +70bp | | | | +10bp | | | | | | | ||||
Operating Margin as adjusted(1) |
| 16.6% | | | +70bp | | | | +70bp | | | | +140bp | | | ||||
Diluted EPS |
| $ | 2.95 | | | (12)% | | | | 1.5% | | | | 2.7% | | | |||
Diluted EPS as adjusted(1) |
| $ | 4.51 | | | 30% | | | | 13.7% | | | | 11.3% | | | |||
Diluted EPS as adjusted in constant currency(1) |
| $ | 4.31 | | | 24% | | | | N/A | | | | N/A | | | |||
Return on Invested Capital as adjusted(2) |
| 21.1% | | | +220bp | | | | 50bp | | | | 310bp | | | ||||
Cash Flow from Operations |
| $ | 2.6 billion | | | 43% | | | | 9.8% | | | | 16.0% | | | |||
Total Stockholder Return ("TSR") |
| 50.4% | | | | | | | 19.7% | | | | 18.2% | | | ||||
TSR S&P 500 Composite |
| 14.3% | | | | | | | 11.9% | | | | 13.4% | | |
| | |
38 | 2018 Proxy Statement |
|
|
July 2014 implementation of its Strategic Modernization Initiative ("SMI"). Fiscal 2013 has also been adjusted to exclude interest expense on debt extinguishment. Fiscal 2018 Net Sales as adjusted in constant currency excludes the $325 million favorable impact of foreign currency translation. Fiscal 2018 Diluted EPS as adjusted in constant currency excludes the $.20 impact of foreign currency translation. See Appendix A for reconciliation and other information about these non-GAAP financial measures.
In fiscal 2018, we increased the common stock dividend 12%, repurchased 6 million shares of our Class A Common Stock for $759 million, and used $629 million of cash flow from operations for capital expenditures. Over the five-year period ended June 30, 2018, the total market value of the Company increased by over 100% or approximately $26 billion.
The following summarizes key executive compensation matters in connection with strong and sustained individual and company performance:
| | |
|
|
2018 Proxy Statement | 39 |
Advisory Vote on Executive Compensation
At the 2017 Annual Meeting, approximately 98% of the votes cast in connection with the stockholders advisory vote on compensation of the NEOs were cast in favor of the proposal, and we have considered this voting result. As explained below, our compensation policies and decisions continue to be focused on sustainable financial performance and aligning the interests of senior management with the interests of stockholders.
Overview of Compensation Philosophy and Objectives
Our compensation program for executive officers is designed to attract and retain world class talent and to motivate them to achieve both our long-term and short-term goals. We believe that the design and governance of our program supports, and aligns executive officers with, the business strategy and the overall goal to continue sustainable growth of net sales, profitability, and return on invested capital on an annual and long-term basis. Our executive compensation program reflects our successful track record and the control by the Lauder family. Periodically, we review various aspects of our compensation program to ensure that it remains aligned with our business strategy and the above-referenced goals. From time to time, we may discuss various topics, including executive compensation and corporate governance matters, with investors and other stakeholders.
Key features of our compensation programs, policies, and practices are as follows:
Align pay with performance and the interests of stockholders by linking a significant portion of total compensation to the achievement of Company-wide performance criteria during one- and three-year performance periods | |||
Deliver approximately one-third of the value of annual equity awards in PSUs, with failure to achieve the pre-established minimum threshold amount resulting in no payout under the PSUs |
|||
Conduct an annual evaluation about risk in compensation programs to confirm that our compensation programs are not reasonably likely to have a material adverse effect on the Company |
|||
Maintain stock ownership guidelines and holding requirements for Executive Officers to further align their interests with those of our stockholders |
|||
Retain a compensation consultant that is free of conflicts of interest, reports directly to the Committee, and performs no other services for the Company |
|||
Do not reprice or buy out stock options |
|||
Maintain policies on insider trading and clawbacks |
Our executive compensation program is designed to achieve our business and financial goals by providing compensation that:
| | |
40 | 2018 Proxy Statement |
|
|
Below are our Named Executive Officers as of June 30, 2018.
Name | Title | |
William P. Lauder | Executive Chairman | |
Fabrizio Freda | President and Chief Executive Officer | |
Tracey T. Travis | Executive Vice President and Chief Financial Officer | |
John Demsey | Executive Group President | |
Cedric Prouvé | Group President International |
Employment agreements in effect during fiscal 2018 for our NEOs are described under "Employment Agreements." Our standard employment agreements for executive officers cover termination and severance and include non-competition, confidentiality, and related provisions. They do not include specified amounts of salary, bonus opportunities, or equity-based compensation for future years. For executive officers who are recruited to join the Company, we will specify levels of salary, bonus opportunities, and equity-based compensation grants for certain initial periods or that relate to initial grants (e.g., to compensate the officer for amounts or awards that may be forfeited at a prior employer).
The compensation program for executive officers is established and administered by the Committee and the Subcommittee. The Subcommittee approves the terms of all equity grants to executive officers under our long-term equity incentive plan (including any equity compensation-related terms of employment agreements for executive officers). The Committee approves all other aspects of executive compensation.
| | |
|
|
2018 Proxy Statement | 41 |
Elements of Compensation
Our executive compensation program for fiscal 2018 generally consisted of the following:
The Committee, Subcommittee, and our senior management begin their review of compensation by looking first at the components of total direct compensation, gauging, for each type of position in the executive officer group, the extent to which total direct compensation is broadly aligned with that of our executive compensation peer group. The Committee, Subcommittee, and our senior management then review the elements of compensation (i.e. base salary, annual cash incentive bonus opportunities, and long-term equity-based compensation opportunities) and determine a mix of these elements as a percentage of total direct compensation. The mix is intended to be performance based (i.e. provide a greater percentage of compensation in the form of variable annual and long-term incentive compensation) and reasonable when compared with the peer group. As shown below, the CEO annual target pay mix for fiscal 2018 was 88% performance based, and the average annual target pay mix for certain other NEOs for fiscal 2018 was 85% performance based. Executive officers with similar responsibilities generally have a similar mix of pay elements. There is internal pay equity among similarly situated executive officers, which is intended to foster a team oriented approach to managing the business. Total direct compensation and allocations of metrics within the EAIP are determined based on the type and level of responsibility of the particular executive officer, internal pay equity, and competitive considerations.
Generally, we believe that executive officers should have a greater percentage of their compensation based on performance in the form of long-term equity-based incentives ("LTI"), followed by annual cash incentives, and then by base salary.
| | |
42 | 2018 Proxy Statement |
|
|
Based on target levels for incentive compensation for fiscal 2018, the mix of pay for executive officers is shown below:
We Align Executive Compensation with Our Business Strategy and Goals. We intend for our annual and long-term incentive plans to cover a portfolio of performance measures that balance growth, profitability, and stockholder return over both an annual and long-term period. We work to establish goals that support the long-term strategy of growing sales 1% to 2% ahead of global prestige beauty, improving operating margin, achieving competitive levels of return on invested capital, and optimizing inventory.
Target levels of performance for a given fiscal year are determined based on our internal planning and forecasting processes and are benchmarked against select peer companies. The Committee and the Subcommittee consider various factors including the expected performance of our competitors and our long-term strategy in establishing the performance required to achieve the maximum payout under each measure for both our annual cash and long-term incentive plans.
In addition to total direct compensation described above, we also provide competitive benefits and modest perquisites. In certain circumstances, we may pay amounts or grant equity to attract executives to work for us or move to particular locations, or we may provide additional incentives for executives to perform or remain with us. This reflects, in part, the global nature of our business and the executives that we seek to attract and retain.
Base Salary
We pay base salaries to provide executives with a secure base of cash compensation. In determining the amount of base salary for an executive officer, the Committee primarily considers the executive's position, current salary, tenure, and internal pay equity among executives with similar responsibilities, as well as competitiveness of the salary level in the marketplace. The Committee also considers recommendations from the Executive Chairman, the President and Chief Executive Officer, the Executive Vice President Global Human Resources, and the Committee's outside consultant (Semler Brossy Consulting Group), as well as certain tax matters. See "Tax Deductibility Considerations" below.
| | |
|
|
2018 Proxy Statement | 43 |
Annual Incentive Bonus
Annual incentives provided under the EAIP are of key importance in aligning the interests of our executives with our short-term goals and rewarding them for performance. For executive officers, the level of bonus opportunities and performance targets are based on the scope of the executive's responsibilities, internal pay equity among executives with similar responsibilities, and competitive considerations. The measures in our annual incentive program are designed to foster interdependence and collaboration among brands, regions, and functions to drive the corporate strategy by ensuring alignment of business unit performance with overall corporate performance. Annual incentives payable to our executive officers, including the NEOs, are limited to a pool set at the beginning of the fiscal year by the Committee (3% of our net operating profit in fiscal 2018). Within that limit, the Committee sets annual aggregate bonus opportunities and exercises negative discretion to determine the annual incentives to be paid. For fiscal 2018, the EAIP payout was the product of the target for each executive officer and the EAIP payout percentage ("EAIP Payout %"), which is comprised of (a) the Corporate Multiplier and (b) the Business Unit Multiplier, as described below. Total EAIP payouts were less than the amount of the bonus pool.
Target level performance on each of the criteria would result in multipliers at 100% and payout at 100% of the executive officer's target opportunity. Provided the minimum threshold has been achieved, payouts can range from 31.25% of target up to a maximum of 150% of target. Failure to achieve the pre-established minimum threshold level of performance would result in no credit for that particular criteria and, depending upon performance in respect of other criteria, could result in no bonus being paid. Measurement of performance, including establishment of the bonus pool, is subject to certain automatic adjustments, such as changes in accounting principles, goodwill and other intangible asset impairments, the impact of unplanned completed business acquisition activity, restructuring and other activities, discontinued operations, certain non-recurring income/expenses, and the impact on net sales of unplanned changes in foreign currency rates. Such automatic adjustments in fiscal 2018 include the impact of charges associated with restructuring and other activities related to the Company's Leading Beauty Forward initiatives, changes in fair value of contingent consideration, the impact of the provisional adjustments resulting from the enactment of the TCJA, and impacts from the accounting change for stock compensation relating to excess tax benefits.
The target payout, business criteria, performance levels within each multiplier, and the threshold, target, and maximum payouts associated with each criteria and performance level were set by the Committee in consultation with management and the Committee's outside consultant during the first quarter of the fiscal year. Target payouts for executive officers are largely based on the prior year's target amount and are reviewed by the Committee annually.
| | |
44 | 2018 Proxy Statement |
|
|
Corporate Multiplier. The Corporate Multiplier is comprised of four equally weighted, Company-wide performance criteria: (1) diluted net earnings per share from continuing operations ("Diluted EPS"); (2) Operating Income Margin Percentage ("OI Margin Percent"); (3) Net Sales; and (4) return on invested capital ("ROIC"). If actual performance is between the target and the maximum, or between the threshold and the target, the payout factor is calculated mathematically using straightline interpolation with target level of performance as a base. As an example, for Net Sales performance that is between the threshold and the target, for each 1% that performance is below target, the payout will be 31/3% below the target payout of 100%. The chart below shows the threshold, target, and maximum for each criteria making up the Corporate Multiplier as well as the results for fiscal 2018. Because performance exceeded the maximum level for each of the four performance criteria, the payout factor was at 120% of target. The Corporate Multiplier was therefore 120%. Each executive officer's incentive payment is subject to the Corporate Multiplier.
|
| | | Threshold | Target | Maximum |
Actual Performance(1) |
| |||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||
|
|
Fiscal 2018 Target |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
| ||||||||||||||||||||||||||||||||
Diluted EPS |
| $3.69 | | | 50 | % | | | 50 | % | | | 100 | % | | | 100 | % | | | 101.9 | % | | | 120 | % | | | 118.7 | % | | | 120.0 | % | | ||||||||
OI Margin Percent |
| 16.3% | | | 50 | % | | | 50 | % | | | 100 | % | | | 100 | % | | | 100.9 | % | | | 120 | % | | | 101.8 | % | | | 120.0 | % | | ||||||||
Net Sales |
| $12.51 billion | | | 85 | % | | | 50 | % | | | 100 | % | | | 100 | % | | | 100.9 | % | | | 120 | % | | | 106.2 | % | | | 120.0 | % | | ||||||||
ROIC |
| 16.7% | | | 50 | % | | | 50 | % | | | 100 | % | | | 100 | % | | | 102.1 | % | | | 120 | % | | | 122.7 | % | | | 120.0 | % | | ||||||||
Corporate Multiplier |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 120.0 | % | |
Business Unit Multiplier. The Business Unit Multiplier works similarly, but is based on various combinations of business criteria at the business unit level, including: (1) Net Sales; (2) Net Operating Margin ("NOP Margin"); (3) inventory management; (4) productivity and other cost savings; and (5) other divisional goals tied to our long-term strategy ("Business Unit Strategic Objectives"). The weighting of the various measures is fixed for each executive officer depending upon position and responsibilities. To ensure better focus on key goals, we eliminated certain metrics and shifted the weightings of some of the measures for the fiscal 2018 EAIP program. As with the Corporate Multiplier, target level performance on all the applicable criteria leads to a Business Unit Multiplier of 100%. If the threshold level of performance is not achieved for any of the applicable criteria, then the Business Unit Multiplier would be zero for those criteria. When performance exceeds the maximum level, the payout factors are at 125% of target. In the case where the actual performance was between the target and the maximum, or between the threshold and the target, the payout factor was calculated mathematically using straightline interpolation with target level of performance and associated payout as a base.
For the Business Unit Multiplier, the Functions Average is a simple average of the performance against Business Unit Strategic Objectives for six Corporate Functions (i.e, Finance; Human Resources; Legal; Global Communications; Global Research and Development, Corporate Product Innovation, Package Development; and Global Supply Chain). For Messrs. Demsey and Prouvé, the threshold, target, and maximum for each criteria making up the Business Unit Multiplier for their
| | |
|
|
2018 Proxy Statement | 45 |
respective units, as well as the results for fiscal 2018, are shown in the table set forth below. This table reflects the move to one inventory metric, Days to Sell (DTS).
|
| | | Threshold | Target | Maximum |
Actual Performance(1) |
| |||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||
|
|
Fiscal 2018 Target |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
| ||||||||||||||||||||||||||||||||
Net Sales |
| | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
John Demsey |
| $7.3 billion | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 100.9 | % | | | 125 | % | | | 96.9 | % | | | 92.2 | % | | ||||||||
Cedric Prouvé |
| $8.1 billion | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 100.9 | % | | | 125 | % | | | 110.8 | % | | | 125.0 | % | | ||||||||
NOP Margin |
| | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
John Demsey |
| 20.9% | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 101.0 | % | | | 125 | % | | | 85.6 | % | | | 64.0 | % | | ||||||||
Cedric Prouvé |
| 33.2% | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 100.5 | % | | | 125 | % | | | 104.4 | % | | | 125.0 | % | | ||||||||
Inventory Management Days |
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
John Demsey |
| 173 | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 105.0 | % | | | 125 | % | | | 88.2 | % | | | 70.4 | % | | ||||||||
Cedric Prouvé |
| 117 | | | 85 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 105.0 | % | | | 125 | % | | | 91.0 | % | | | 77.5 | % | | ||||||||
Productivity |
| | | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
John Demsey |
| $532 million | | | 90 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 103.0 | % | | | 125 | % | | | 107.6 | % | | | 125.0 | % | | ||||||||
Cedric Prouvé |
| $773 million | | | 90 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 103.0 | % | | | 125 | % | | | 102.1 | % | | | 117.2 | % | | ||||||||
Productivity |
|
| | | | | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||
John Demsey |
| 7.1% | | | 90 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 105.0 | % | | | 125 | % | | | 101.5 | % | | | 107.3 | % | | ||||||||
Cedric Prouvé |
| 9.3% | | | 90 | % | | | 62.5 | % | | | 100.0 | % | | | 100.0 | % | | | 105.0 | % | | | 125 | % | | | 110.1 | % | | | 125.0 | % | |
Ms. Travis, Mr. Demsey, and Mr. Prouvé were each assigned Business Unit Strategic Objectives for fiscal 2018 that accounted for the percentages of the individual's aggregate bonus opportunity target indicated below.
These Business Unit Strategic Objectives are aligned with high-level themes, explained below, that help focus collective efforts in areas that are important to shared success across business units and drive the corporate strategy.
After the end of fiscal 2018, the Executive Chairman, the President and Chief Executive Officer, and the Executive Vice President Global Human Resources, with appropriate input from other employees, reviewed the actions taken by each Group President and the Executive Vice President and Chief Financial Officer in connection with the Business Unit Strategic Objectives and, based on that assessment, recommended the payout percentages shown in the table below (with a maximum of 125%). The assessment of these achievements and payouts were confirmed by the Committee in its business judgment.
| | |
46 | 2018 Proxy Statement |
|
|
Calculation of EAIP Payout Percentage. As noted, the weightings of the various criteria for an executive officer's Business Unit Multiplier depend upon the officer's position and responsibilities, as shown in the calculation of the Business Unit Multiplier below.
For each NEO, the calculation of the individual's EAIP Payout % for fiscal 2018, including both the Business Unit Multiplier (weighted accordingly) and the Corporate Multiplier is as follows:
|
| |
| |
| |
| |
| |
| |
| |
| |
| |
||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
W. P. Lauder & F. Freda |
T.T. Travis | J. Demsey | C. Prouvé | |||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||
|
|
% of Target |
Actual payout % |
% of Target |
Actual payout % |
% of Target |
Actual payout % |
% of Target |
Actual payout % |
|||||||||||||||||||||||||||||||||
Functions Average |
| | 25 | % | | | 117.2 | % | | | 10 | % | | | 117.2 | % | | | 10 | % | | | 117.2 | % | | | 10 | % | | | 117.2 | % | | |||||||||
Business Unit Strategic Objectives |
| | | | | | | | 30 | % | | | 125.0 | % | | | 15 | % | | | 102.0 | % | | | 15 | % | | | 125.0 | % | | |||||||||||
Division Net Sales(1) |
| | 25 | % | | | 125.0 | % | | | 20 | % | | | 125.0 | % | | | 25 | % | | | 92.2 | % | | | 25 | % | | | 125.0 | % | | |||||||||
Division NOP Margin(1) |
| | 25 | % | | | 125.0 | % | | | 20 | % | | | 125.0 | % | | | 25 | % | | | 64.0 | % | | | 25 | % | | | 125.0 | % | | |||||||||
Inventory Management |
| | 15 | % | | | 76.2 | % | | | 10 | % | | | 76.2 | % | | | 15 | % | | | 70.4 | % | | | 15 | % | | | 77.5 | % | | |||||||||
Productivity |
| | 10 | % | | | 125.0 | % | | | 10 | % | | | 125.0 | % | | | 10 | % | | | 116.2 | % | | | 10 | % | | | 121.1 | % | | |||||||||
| | | | | | | | | | | | | | | | | | | ||||||||||||||||||||||||
Business Unit Payout (a) |
| | 100 | % | | | 115.7 | % | | | 100 | % | | | 119.3 | % | | | 100 | % | | | 88.3 | % | | | 100 | % | | | 116.7 | % | | |||||||||
Corporate Multiplier (b) |
| | | | | 120.0 | % | | | | | | 120.0 | % | | | | | | 120.0 | % | | | | | | 120.0 | % | | |||||||||||||
EAIP Payout % (a) x (b) |
| | | | | | 138.9 | % | | | | | | | 143.2 | % | | | | | | | 105.9 | % | | | | | | | 140.0 | % | | |
For more information about the potential bonus opportunities of our NEOs for fiscal 2018 and the actual payouts made in September 2018 in respect of fiscal 2018 performance, see "Grants of Plan-Based Awards in Fiscal 2018" and "Summary Compensation Table."
Long-Term Equity-Based Compensation
We consider equity-based compensation awarded under our Amended and Restated Fiscal 2002 Share Incentive Plan (the "Share Incentive Plan") to be of key importance in aligning executives with our long-term goals and rewarding them for performance. The awards also provide an incentive for continued employment with us. We grant certain executive officers a combination of PSUs, stock options, and RSUs. Since fiscal 2000, no grants of equity-based compensation have been made to Leonard A. Lauder, Chairman Emeritus, or Ronald S. Lauder, Chairman of Clinique Laboratories, LLC. The Subcommittee typically makes equity-based compensation awards to our executive officers at its regularly scheduled meeting during the first quarter of each fiscal year. There is no relationship between the timing of the grants of equity-based awards and our release of material, non-public information.
The target and actual amounts and allocation of equity-based compensation reflect the business judgment of the Subcommittee after discussion with its outside consultant and certain members of our senior management. As with each other element of compensation, and compensation overall, the Subcommittee (or the Committee for non-equity-based compensation), its outside consultant, and management take into account the level of responsibility of the particular executive officer, recent performance and expected future contributions, internal pay equity, and competitive practice. They also consider applicable employment agreements as necessary.
The allocation among the value of the different types of annual awards granted in fiscal 2018 is weighted equally among PSUs (at target), stock options, and RSUs reflecting, in the business judgment of the Subcommittee, a balance among motivating and retaining executive officers, rewarding performance, mitigating risk, and helping executive officers increase their equity
| | |
|
|
2018 Proxy Statement | 47 |
ownership to further align their interests with those of our stockholders. Such allocation may change depending upon any supplemental grants made to executive officers.
No specific weightings were used to determine the amounts of the equity-based compensation. The Subcommittee applied an individual performance factor to the target equity opportunity for each executive officer. The performance factors ranged from 117% 135% of target. As with the amount of equity-based compensation granted, the allocation among the equity-based compensation elements are compared with practices of the peer group companies (see "Compensation Planning and the Decision Making Process Peer Group" below) to ensure they are competitive and appropriate.
Performance Share Units. Annual PSUs represent approximately one-third of the grant date value of the equity-based compensation granted to executive officers. PSUs are generally rights to receive shares of our Class A Common Stock if certain Company-wide performance criteria are achieved during a three-year performance period. PSUs are expressed in terms of opportunities, and each opportunity is based on a particular financial metric that is considered important in achieving our overall long-term financial goals.
For the annual grant of PSUs, the Subcommittee approves the performance target for each metric during the first quarter of the three-year performance period. Each opportunity is expressed in shares to be paid out if performance equals 100% of the target. PSUs are accompanied by dividend equivalents that are accrued and paid in cash at the end of the performance period. To the extent shares are paid out on a PSU award, the cash amount paid is equal to the dividends declared per share over the performance period times the number of shares paid out. The target amount of a PSU award represents the aggregate payout if the performance of all opportunities equal 100% of the related target performances. An above-target payout can be achieved under a particular opportunity if the performance associated with such opportunity exceeds 100% of the target, up to a maximum of 150% of target. Failure to achieve the pre-established minimum threshold amount would result in no payout being made under the opportunity.
Measurement of performance is subject to certain automatic adjustments described above in "Annual Incentive Bonus." Payout of PSUs is contingent on the Company achieving positive Net Earnings for the fiscal year in which the grant is made. Because the Company achieved positive Net Earnings for fiscal 2018, the payout of the PSUs granted in September 2017 is based solely on achievement of the financial measures described below in "Fiscal 2018 PSU Grants."
Fiscal 2016 PSU Grants. The PSU targets for the three-year period ended June 30, 2018 were based on compound annual growth rates ("CAGR") in Company-wide Net Sales, Diluted EPS, and ROIC, weighted equally. Each 1% increase in performance over the threshold results in a 5% increase in associated payout for Net Sales and 31/3% increases in associated payouts for Diluted EPS and ROIC up to the target performance levels. Each 1% increase in performance above target results in 38.6%, 11.8%, and 16.4% increases in associated payouts for Net Sales, Diluted EPS, and ROIC, respectively. Performance above maximum results in a payout of 150% of target opportunity.
For the PSUs that were paid out after the end of fiscal 2018 (specifically, in September 2018), the aggregate payout of the three measures, weighted equally, was 150% because all measures
| | |
48 | 2018 Proxy Statement |
|
|
exceeded the maximum results. The table below summarizes the measures and corresponding payouts.
|
|
Fiscal 2016 through |
Threshold | Target | Maximum |
Actual Performance(2) |
||||||||||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | | | | | |||||||||||||||||||||
|
|
Fiscal 2018 Target |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
||||||||||||||||||||||||||||||||
Net Sales (CAGR)(1) |
| | 6.80 | % | | | 90 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 101.3 | % | | 150 | % | | 102.5 | % | | 150.0 | % | | |||||||||
Diluted EPS (CAGR) |
| | 7.50 | % | | | 85 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 104.2 | % | | 150 | % | | 120.3 | % | | 150.0 | % | | |||||||||
ROIC (CAGR) |
| | 5.30 | % | | | 85 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 103.0 | % | | 150 | % | | 130.5 | % | | 150.0 | % | | |||||||||
Aggregate Payout |
| | | | | | | | | | | | | | | | | | | | | | 150.0 | % | |
Fiscal 2018 PSU Grants. The targets for the PSU opportunities and corresponding payouts for PSUs granted in fiscal 2018 for the three-year period ending June 30, 2020 are based on CAGR in Company-wide Net Sales, Diluted EPS, and ROIC, weighted equally, as follows:
|
|
Fiscal 2018 through |
Threshold(2) | Target | Maximum | |||||||||||||||||||||||||||||
| | | | | | | | | | | | | | | | | | |||||||||||||||||
|
|
Fiscal 2020 Target |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
% of Target |
Payout (% of Oppty) |
||||||||||||||||||||||||||
Net Sales (CAGR)(1) |
| | 7.00 | % | | | 90 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 101.4 | % | | 150 | % | | |||||||
Diluted EPS (CAGR) |
| | 9.70 | % | | | 85 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 102.8 | % | | 150 | % | | |||||||
ROIC (CAGR) |
| | 4.60 | % | | | 85 | % | | | 50 | % | | | 100 | % | | | 100 | % | | 103.7 | % | | 150 | % | |
The goals above were based on the long-term strategic plan and the conditions that existed at the start of fiscal 2018. We believe the targets when set were reasonably aggressive.
Additional PSU Grants. From time to time, the Subcommittee makes grants of additional PSUs to executive officers. For information relating to the additional PSUs granted to Mr. Freda in fiscal 2018 and in fiscal 2016, see "CEO Compensation" below and "Outstanding Equity Awards at June 30, 2018." The additional PSU grant made to John Demsey on January 28, 2016 (fiscal 2016) is reflected in "Outstanding Equity Awards at June 30, 2018."
| | |
|
|
2018 Proxy Statement | 49 |
Stock Options. Annual stock options represent approximately one-third of the grant date value of the equity-based compensation granted to executive officers. We believe that stock options are performance-based because the exercise price is equal to the closing price of the underlying Class A Common Stock on the date the option is granted. Under our Share Incentive Plan, the exercise price of options cannot be lower than such closing price. Despite the value attributed on the date of grant for accounting purposes, value is realized by the executive officer only to the extent that the stock price exceeds such price during the period in which the executive officer is entitled to exercise the options and the officer exercises them. Options granted to our executive officers generally become exercisable in three equal installments approximately 16 months, 28 months, and 40 months after the date of grant, and expire ten years from the grant date.
Restricted Stock Units. Annual RSUs represent approximately one-third of the grant date value of the equity-based compensation granted to executive officers. RSUs are the right to receive shares of our Class A Common Stock over a period of time. RSUs are granted to executive officers to serve as a retention mechanism and to help them build their equity ownership. RSUs are accompanied by dividend equivalents that are paid in cash; at the time an RSU vests, the cash amount paid to the executive officer is equal to the dividends declared per share between the grant date and the vesting date multiplied by the number of shares paid out. RSUs granted to our executive officers generally vest in three equal installments approximately 14 months, 26 months, and 38 months from the date of grant.
Additional RSU Grants. From time to time, the Subcommittee makes grants of additional RSUs to executive officers. For example, on September 6, 2016 (fiscal 2017), the Subcommittee granted Tracey T. Travis, Executive Vice President and Chief Financial Officer, an additional RSU award that is reflected in "Outstanding Equity Awards at June 30, 2018."
Equity-Based Compensation Granted in Fiscal 2018. As noted above, target award levels and actual grants of equity made to executive officers are determined by taking into account many factors, including an assessment of recent performance and expected future contributions. For the Executive Chairman and the President and Chief Executive Officer, this determination is made by the Subcommittee; for the remaining executive officers, a recommendation is made by the executive officer's immediate manager, and the actual grant is approved by the Subcommittee. Fiscal 2018 annual equity grants were awarded in September 2017; the resulting equity grant percentages awarded to our NEOs in fiscal 2018 were based on target grant levels and an assessment of each officer's performance and expected future contributions. See "Grants of Plan-Based Awards in Fiscal 2018" and "Summary Compensation Table."
CEO Compensation
Throughout his tenure, and particularly in fiscal 2018, Mr. Freda demonstrated continued outstanding performance and leadership as our Chief Executive Officer. Some highlights of our fiscal 2018 results are noted in the "Executive Summary" above. Since becoming President and Chief Executive Officer in July 2009, Mr. Freda has led the development and implementation of our long-term strategy. Between that time and June 30, 2018, (i) we have achieved TSR of 872%, placing us among the top 7% of S&P 500 companies (the TSR of the S&P 500 Index was 257%); and (ii) our market capitalization has increased by $45 billion to $52 billion.
In recognition of Mr. Freda's leadership and expected future contributions, as well as our strong multi-year performance, the Committee and the Subcommittee increased Mr. Freda's total direct annual compensation for fiscal 2018 by 4% to $15.68 million, and the Subcommittee approved an additional PSU grant in February 2018 that is discussed below. For fiscal 2018, Mr. Freda's annual equity target increased to $8.88 million (from $8.48 million), his base salary remained at $1.9 million, and his target bonus opportunity increased to $4.9 million (from $4.7 million).
| | |
50 | 2018 Proxy Statement |
|
|
Additional PSU Grant in February 2018 (fiscal 2018). On February 14, 2018, the Stock Plan Subcommittee, with input from members of the Board of Directors, granted a PSU award (the "February 2018 PSU") to Mr. Freda to further align his interests with those of our stockholders and motivate his continued stewardship of the Company's brands, talent base, and reputation over the longer term. The shares of Class A Common Stock subject to this award are not intended to be delivered fully to Mr. Freda until after the end of fiscal 2024, which reflects the Company's desire to further align his interests with those of our stockholders over that extended period of time. The award covers an aggregate of 195,940 shares divided in two equal tranches (i.e. 97,970 shares per tranche). The aggregate grant date value of the award (both tranches) is approximately $27.4 million, based on the closing price of our Class A Common Stock on the date of grant.
The service periods, performance periods and share payment dates for the February 2018 PSU are as follows:
|
| Service Period |
Performance Period |
Share |
||
First Tranche (97,970 shares) |
| January 1, 2018 June 30, 2021 | | July 1, 2018 June 30, 2021 | | September 3, 2024 |
Second Tranche (97,970 shares) |
| January 1, 2018 June 30, 2022 | | July 1, 2018 June 30, 2022 | | September 3, 2024 |
In its comprehensive and thoughtful consideration of the appropriate size and structure for the February 2018 PSU grant, the Subcommittee considered the input from its consultant and other Board members, as well as the feedback and concerns received from some institutional investors following the September 2015 differentiated long-term award to Mr. Freda. Ultimately, the Subcommittee determined that the February 2018 grant was appropriate and consistent with the Company's long-term business and compensation strategy, providing an incentive for sustainable and effective stewardship of the Company's brands, talent base, and reputation over an extended period of time.
In setting the performance goal for the February 2018 PSU, the Stock Plan Subcommittee determined that any absolute or relative goals would become meaningless or counterproductive in light of a rapidly evolving competitive environment. The performance goal is intended to prevent this award from vesting if our performance were to suffer a substantial reversal during the vesting period and is accompanied by carefully considered payout restrictions around termination scenarios as described below.
The February 2018 PSU covers a period of about six-and-a-half years in total and involves two separate tranches that vest after three-and-a-half and four-and-a-half years based on Mr. Freda's continued employment and achievement of the performance goal described above. If the performance goal for a tranche is achieved, the shares of common stock underlying such tranche would be paid out to Mr. Freda in September 2024, a period of time that is much longer than typical grants. The delayed distribution feature is a key component of the award, intended to ensure that Mr. Freda is further incentivized to drive long-term performance. By separating award vesting from delivery of the underlying common stock, we continue to tie a portion of Mr. Freda's wealth to share value over an extended time horizon (i.e. six-and-a-half years, through the delivery in September 2024).
This award generally provides that the vesting of each tranche is contingent on the Company achieving positive Cumulative Operating Income during the relevant Performance Period. For purposes of this award, "Cumulative Operating Income" means the sum of the operating income for each fiscal year in such Performance Period, subject to certain automatic adjustments including:
| | |
|
|
2018 Proxy Statement | 51 |
changes in accounting principles; impairment of intangibles; impact of discontinued operations; non-recurring and non-operating income and expenses; and the impact of unplanned acquisitions.
If Mr. Freda's employment is terminated for cause, as defined in the February 2018 PSU award agreement, prior to the delivery of the shares associated with any tranche, regardless of whether that tranche has been otherwise earned or vested, he will receive no shares. If (a) Mr. Freda is no longer employed by us for any reason, (b) payment of a tranche has not previously been made, and (c) it is determined that his behavior while he was employed would have constituted cause, then each tranche not previously paid will be forfeited, regardless of whether such tranche has been otherwise earned and vested. In addition, payouts of the award after termination of Mr. Freda's employment are subject to Mr. Freda not (x) competing with the Company during the lesser of (i) the remaining term of his award or (ii) a period of 24 months, nor (y) conducting himself in a manner adversely affecting the Company. If he voluntarily resigns or retires prior to the end of the Service Period, any unearned, unvested tranches will be forfeited. If Mr. Freda's employment is terminated without cause, then for each Performance Period that has not yet concluded and subject to actual achievement of the performance goal for such tranche, he will earn and vest in the pro rata portion of such tranche inclusive of credit for an additional 12 months of service (up to a maximum of 100% of the Service Period for that tranche). However, instead of a pro rata portion, Mr. Freda would earn and vest fully in such tranche if the Company also has achieved Company-wide performance criteria (currently known as the "corporate multiplier") under the Company's Executive Annual Incentive Plan of at least 90% for each of the Company's two fiscal years preceding the year of Mr. Freda's termination, as determined by the Compensation Committee. If Mr. Freda dies or becomes disabled, then for each Performance Period that has not yet concluded, he will earn and vest in a pro rata portion of such tranche, and the share payment would be made shortly thereafter. Upon a Change in Control, the performance goal will be deemed to be met, and the award will be paid on the earliest of the original payment date, shortly after a qualifying "double trigger" termination of employment, or a date determined by the Stock Plan Subcommittee in accordance with the Plan. Dividend equivalents will be paid out in cash in connection with shares that are earned.
Additional PSU Grant in September 2015 (fiscal 2016). The size and structure of the February 2018 PSU described above, as well as the reasons for the grant, are similar to the differentiated long-term grant to Mr. Freda on September 4, 2015 (the "September 2015 PSU"), which is discussed below. The September 2015 PSU award reflected the Company's strong performance, the importance of ensuring the sustainability of the Company's performance and its longer term success, and the desire to retain Mr. Freda and further align his interests with the interests of our stockholders. The Subcommittee also wanted to recognize and provide an incentive for sustainable and effective stewardship of the Company's brands, talent base, and reputation over that extended period of time. The final performance period for the September 2015 grant ends on June 30, 2020, with a payment date of June 30, 2023; the performance periods for the February 2018 PSU end on June 30, 2021 and June 30, 2022, each with a payment date of September 3, 2024. The Company notes that between September 4, 2015 (the grant date of the September 2015 PSU) and June 30, 2018, (i) we have achieved TSR of 94% (the TSR of the S&P 500 Index was 50%); and (ii) our market capitalization increased from $23 billion to $52 billion.
The September 2015 PSU is a long-term equity award that is designed to not be delivered fully to Mr. Freda until the end of fiscal 2023. This PSU grant has a target payout of 387,848 shares and was valued at $30 million on the date of grant. The award is designed to be earned in tranches at the end of certain fiscal years with no shares being delivered to Mr. Freda until the end of subsequent fiscal years as reflected below.